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Abstract
Verification of the clinical implementation of the respiratory gated beam delivery
technique with synchrotron-based proton irradiation
Publication No.________*

Yoshikazu Tsunashima, M.S.

Supervisory Professor: X Ronald Zhu, Ph.D.

The clinical advantage for protons over conventional high-energy x-rays stems from
their unique depth-dose distribution, which delivers essentially no dose beyond the end
of range. In order to achieve it, accurate localization of the tumor volume relative to
the proton beam is necessary. For cases where the tumor moves with respiration, the
resultant dose distribution is sensitive to such motion. One way to reduce uncertainty
caused by respiratory motion is to use gated beam delivery.
The main goal of this dissertation is to evaluate the respiratory gating technique in both
passive scattering and scanning delivery mode. Our hypothesis for the study was that
optimization of the parameters of synchrotron operation and respiratory gating
can lead to greater efficiency and accuracy of respiratory gating for all modes of
synchrotron-based proton treatment delivery. The hypothesis is tested in two

v

specific aims. The specific aim #1 is to assess the efficiency of respiratory-gated
proton beam delivery and optimize the synchrotron operations for the gated proton
therapy. A simulation study was performed and introduced an efficient synchrotron
operation pattern, called variable Tcyc. In addition, the simulation study estimated the
efficiency in the respiratory gated scanning beam delivery mode as well.
The specific aim #2 is to assess the accuracy of beam delivery in
respiratory-gated proton therapy. The simulation study was extended to the passive
scattering mode to estimate the quality of pulsed beam delivery to the residual motion
for several synchrotron operation patterns with the gating technique. The results
showed that variable Tcyc operation can offer good reproducible beam delivery to the
residual motion at a certain phase of the motion. For respiratory gated scanning beam
delivery, the impact of motion on the dose distributions by scanned beams was
investigated by measurement. The results showed the threshold for motion for a variety
of scan patterns and the proper number of paintings for normal and respiratory gated
beam deliveries. The results of specific aims 1 and 2 provided supporting data for
implementation of the respiratory gating beam delivery technique into both passive and
scanning modes and the validation of the hypothesis.
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Chapter 1. Introduction
1.1 The benefit of the application of proton beams in radiotherapy
The idea for the clinical use of protons for cancer therapy was first discussed in the
paper “Radiological Use of Fast Protons” published by Dr. Robart Willson in 1946
(Willson 1946). In 1950, proton beams were first used on human patient treatment by
Tobias et al (1958). Following this early success, research activities on the clinical use
of proton therapies for cancer treatment were initiated at some of the high energy
physics facilities throughout the world (Larsson 1958, Kjellberg 1962). Between 1980
and 1990, hospital-based proton therapy facilities began to be built, and the role of the
proton therapy moved from basic research to the clinic (Slater 1991, Tsujii 1993).
Since 2000, more than 18 proton therapy facilities have been in operation, and proton
therapy is fast becoming an established treatment method in radiation therapy.
The use of proton beams as a source of therapeutic radiation provides a
substantial dosimetric improvement over conventional sources of radiation such as
high-energy x-rays (Tsujii 1993, Shioyama 2003, Chang 2006). This is due to one of
the physical characteristics of proton beams, the Bragg peak, in which protons stop
abruptly in a medium and deliver almost no dose beyond the end of the proton beam
range (Wilson 1946, Bonett 1993, Pedoroni E 1995, Smith 2006). This unique physical
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characteristic brings about a clinical advantage especially for sparing radiation
sensitive Organs at Risk (OAR) (ICRU 62). Dose conformity created by the proton
beams can allow for increased target doses for better local tumor control without
increase in, or even with reduction of, normal tissue toxicities compared to photon
treatment. In order to achieve highly conformal three-dimensional beam delivery in
proton therapy, a sophisticated beam delivery method is employed. The proton beam’s
depth direction conforms to the target shape in the beam axis direction, resulting in the
so-called beam modulation in the depth direction. The proton beam also conforms to
the collimator shape that is based on the 2D data of the target projected into the beam
direction.

1.2 Methods for delivering a 3D proton dose distribution: Passive scattering and
Beam scanning techniques
It is well known that there are two types of 3D uniform field delivery techniques in
proton therapy. One is passive scattering technique (Bonett 1993, Koehler1975 and
1977), which broadens the proton beam in the lateral and depth directions using
scatters and energy modulators. The second is beam scanning, in which the tumor is
“painted” in three dimensions with a narrow proton beam using steering magnets
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(Bonett 1993, Pedoroni E 1995). It is often easier to create a similar or usually more
conformal treatment plan in proton therapy than IMRT, typically with better sparing of
the normal organs from high doses
These techniques have been developed to create conformal dose distributions
that concentrate the dose only to a target volume. The passive scattering method is a
rather classic technique commonly used for many sites, including prostate, head and
neck, liver, esophagus and lung. Especially for liver, esophagus and lung treatment,
Proton Medical Research center in University of Tsukuba has a lot of clinical
experience with the passive scattering method (Nakayama 2009, Sugawara 2005,
Shioyama 2003). The scanning beam technique is newer and is currently used in fewer
proton centers. It offers the possibility of higher conformality and obviates the need for
compensators and energy modulators. From a historical point of view, the scanning
techniques have been used selectively for the organs that do not move much during
beam delivery because the protons in principle stop at the same point as long as the
beam path length is constant. However, if the organ moves, the beam path
consequently changes due to the motion. In this case, the proton’s end of range is
unpredictable, and this may cause either overdosage to the target and/or surrounding
organs or underdosage to the target in passive scattering method (Engelsman 2006).
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On the other hand, for the scanning mode the over and under dosage occur scan layer
by layer due to the organ motion. The total delivered dose to the target is so
deteriorated that it is very hard to predict the actually dose on the treatment planning. It
is important to note that motion affects the resulting dose distributions for both passive
and scanning mode, and this may be of particular importance for hypo-fractionated
treatments where there is not adequate time for the dose distributions to be averaged
out by the number of treatment fractions. It is therefore quite important to be overcome
the difficulties in treating mobile organs for both the passive and scanning beam
delivery techniques.

1.3 Difficulties in maximizing the benefits of proton therapy for mobile tumors
In the case of treatment of mobile tumors, maximizing the clinical advantages of
proton therapy is made more difficult due to patient breathing. The target motion
causes not only target misses from the beam delivery field but also undesirable dose
distributions due to range fluctuations and anatomical motion. Thus, although the
proton Bragg peak is fully used as a benefit of the proton therapy, this physical
characteristic sometimes conversely becomes the weakness of proton therapy. This is
because, if the radiological path length is changed due to motion, the protons either do
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not reach or pass beyond the planned depth (Minohara 2003, Mori 2008). This can be
seen in the case of a lung tumor, as described below.
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Figure 1- 1. Variation of the dose distribution in the depth direction due to target
motion. Red contour: the IGTV. Blue contour: the CTV. Left: the ideal case in which
the IGTV and CTV fully covered and the dose distribution terminates abruptly after
the target. Middle: Ph00 represents the full inspiration phase Right: ph60 represents an
expiration phase. In both breathing phases, high dose areas extend beyond the target
and the IGTV and CTV are not fully covered.
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Figure 1-1 shows the variation in the radiological path lengths due to target motion.
The Gross Tumor Volume (GTV) accounting for tumor motion (termed the Internal
Gross Tumor Volume (IGTV)) and the Clinical Target Volume (CTV) were created
from the Maximum Intensity Projection CT (MIP) made from a 10-phase 4DCT data
set covering the entire range of breathing motion. The compensator was created on the
Average CT, or the average of the 10 phases. Dose calculations were performed on
each CT data set from phase 0, full inspiration to 60, full expiration. The dose
calculation algorithm used a ray-casting model, which is convenient for the purpose of
expressing proton range information (Chen 1979). The left figure represents an ideal
treatment, in which the IGTV and CTV are fully covered and the dose distribution into
the lung is minimal. However the middle (inspiration phase) and right (expiration
phase) figures show that the ideal plan is barely reflected and the delivered dose
distribution is significantly different due to patient breathing motion. The maximum
depth points change depending on the tumor location, as shown in the doses delivered
at inspiration and expiration phases, and in both cases the dose to the normal lung is
greater than in the ideal case.
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1.4 Necessity for respiratory-gated proton delivery for treating tumors that move
due to patient breathing
The uncertainties caused by patient setup and organ motion can affect the proton dose
distribution inside the patient’s body (Minohara 2003, Mori 2008) In principle,
marginal errors may need to be taken into account to compensate for the uncertainties
in conventional treatment delivery (Engelsman M 2006). For photon therapy, the
margin can be applied to compensate for the entire tumor motion. This is based on the
assumption of free-breathing beam delivery using 4DCT (Kang 2007). However it is
not appropriate to make use of similar concepts for proton therapy because of
increased sensitivity of proton transport to local density changes, as shown in figure
1-1. Therefore we need to handle this as a “proton specific” issue. There are generally
two methods to perform beam delivery with respiratory motion. One is to manage
patient breathing and reduce the magnitude of the patient’s breathing as much as
possible or force the patient’s breathing into a regular motion (Wong 1999, Kini 2003,
Mageras 2004). Inhale and exhale breath hold techniques are also forms of respiratory
management (Mageras 2004). The drawbacks of respiratory management method are,
however, that the uncertainty and accuracy are strongly dependent on operator
(physicist or therapist) and/or patient compliance (Ref, show the proof or paper). An
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alternative method is to synchronize proton beam delivery with the patient’s breathing.
Proton beam delivery is initiated only when the target volume is in a certain phase of
the patient’s respiratory cycle. This technique is called respiratory gating (Inada 1992,
Kubo HD 1996, Shirato H 2000). It is similar to capturing a given moment of target
motion, during which dose are delivered to the target. This is also a snapshot of beam
delivery from the treatment planning point of view. Compared to the full range of
breathing motion, it is much easier to take into account the uncertainty in target motion
associated with gated patient breathing because the range of motion is dramatically
reduced.
Respiratory-gated beam delivery with proton beams is a highly sophisticated
beam delivery method. Because this method selectively uses a fraction of the beam
cycle, beam delivery time becomes a concern and will depend on the specifications of
the accelerator used in a particular proton facility. It is well known that there are two
types of accelerators used for cancer treatment, the cyclotron and the synchrotron. The
main conceptual difference between the two is that the proton beam generated from a
cyclotron is a continuous beam, while the beam from a synchrotron is a pulsed beam
with a certain cycle. This difference considerably influences the beam delivery time
and the quality of beam delivery. With synchrotron-based beam delivery, the
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complicated timing and cycle of beam extraction from the synchrotron greatly affects
the beam delivery. This is not, however, a concern for cyclotron-based beam delivery.
The MD Anderson Proton Therapy Center in Houston (PTCH) employs the
PROBEAT proton beam delivery system (Hitachi America Ltd., Tarrytown, NY) and
is a synchrotron-based proton treatment system. Therefore the following discussion
will focus on the issues associated with synchrotron based beam delivery.

1.5 Review of literature relevant to this study
To date, respiratory-gated proton beam delivery using both passive and beam scanning
methods has not been validated in the literature, although there have been some papers
published for carbon therapy (Minohara 2003, Christoph B 2008, Grozinger2006).
There are a few published papers that deal with proton beam delivery to a moving
target (Paganetti 2005, Kang 2007); however, these simulation studies using the
passive scattering method focus more on the dosimetric impact of free-breathing
motion based on 4D simulation.
The main issue with current realistic treatment planning performed in the
clinic is how to achieve either a planned beam delivery or dose distribution for the
cases with a moving target that is not taken into account in the treatment planning.
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Clinically, treatment planning is performed based on a static or three-dimensional
space, and is not done in a dynamic, so called 4D space.
For the facilities considering using respiratory-gated proton beam delivery, it
is very important to consider the optimized operation of respiratory-gated beam
delivery from both the efficiency and quality in terms of accuracy and precision
viewpoints. Nevertheless, there have not been adequate studies that seriously consider
the feasibility of the respiratory gating technique for synchrotron-based passive
scattering and beam scanning (including Intensity Modulated Proton Therapy, IMPT),
accounting for the trade-off between the efficiency of the beam delivery and the
dosimetric quality.

1.6 Hypothesis
Achieving clinical implementation of respiratory-gated proton beam delivery is a very
urgent mission that will increase the sophistication of proton treatments, especially for
the lung, esophagus and liver. This has been established as the goal of my research. I
have planned and proceeded with research projects based on the following hypothesis:
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“Optimization of the parameters of synchrotron operation and respiratory gating
can lead to greater efficiency and accuracy of respiratory gating for all modes of
synchrotron-based proton treatment delivery.”
The hypothesis was tested using the following specific aims.

Specific aim 1
Assess the efficiency of respiratory-gated proton beam delivery and optimize the
accelerator operations for synchrotron-based gated proton therapy
In synchrotron-based proton beam delivery, optimizing the cycle of the magnet
excitation pattern to synchronize with patient breathing is critical to the efficiency of
respiratory-gated proton delivery. I will design a computer simulation program to
emulate respiratory-gated beam delivery using various operating conditions of the
synchrotron accelerators. Using a realistic simulation with actual patient breathing data,
the efficiency of synchrotron-based respiratory-gated proton beam delivery will be
estimated. From analysis of the results from simulation, we will propose the most
efficient method for synchrotron-based respiratory-gated treatment for both passive
scattering and beam scanning delivery techniques.
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Specific aim 2
Assess the accuracy of beam delivery in respiratory-gated proton therapy
To evaluate the quality of the gated beam delivery, we will evaluate the positional
accuracy of the target volume and the precision of respiratory-gated beam delivery
using a simulation technique. A wide gating window, irregular breathing or imperfect
gating trigger will induce a positional inaccuracy especially for the scanned pencil
beam. The analysis will be done with several patient breathing data sets. In addition to
the simulation, we will conduct an experiment to validate gated treatment delivery
through measurements using films and a motion phantom. Using the motion phantom,
a mobile target will be driven by computer-programmed motion based on patient
breathing data. Film will be placed at the center of the designated target region. An
experiment will be designed to compare measured dose from: 1) the beam delivered to
the moving phantom with no motion, 2) non-gated beam delivery to the moving
phantom and 3) gated beam delivery to the moving phantom. This will be conducted
for both the passive and the beam scanning modes. The trade-off between treatment
delivery accuracy and efficiency will be evaluated. For further evaluation of these
results, it is also important to show the relative benefit to patients who receive
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respiratory-gated treatment compared to non-gated treatment. Such an analysis will
indicate the dosimetric benefits of respiratory-gated proton therapy for mobile tumors.
In order to validate the hypothesis, the purpose of the first research project is to
develop methods to optimize beam delivery of synchrotron-based proton beams for
mobile tumors. To accomplish this, I plan first to conduct a simulation study and a
series of measurements. Secondly, from the results I will determine the efficiency and
quality of synchrotron-based respiratory-gated beam delivery. In the simulation,
several electrical signals from the accelerator operation pattern and the patient’s
respiratory signal information run simultaneously as if the respiratory-gated beam
delivery is virtually performed on the computer. The result obtained from the
simulation will be the basis to improve treatment efficiency and quality. In addition, I
will conduct validation experiments in order to support the simulation results. The
implementation of the optimized beam delivery into clinical practice will allow us to
significantly improve the efficiency and accuracy of proton treatment for lung cancer
patients.
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Chapter 2. Overview of synchrotron and beam delivery system for proton therapy
For this research project, it is very important to understand the characteristics of
synchrotron operation and the operation parameters used in passive scattering and
scanning modes. In this section synchrotron operation specific to the PTCH are
described in detail.

2.1 Synchrotron-based proton beam delivery system at the University of Texas
MD Anderson Cancer Center
The Proton Therapy Center at Houston (PTCH) at the MD Anderson Cancer employs
the PROBEAT proton beam delivery system (Hitachi America Ltd., Tarrytown, NY).
This synchrotron-based proton treatment system governs the treatment rooms, all
control systems and other components associated with treatments. The PTCH has three
treatment rooms with rotating gantries, two equipped for passive scattering mode and
one for beam scanning mode, two fixed beam line treatment rooms, a synchrotron with
a beam transport system and the control system (figure 2-1). The synchrotron at PTCH
is 23 m in circumference and can accelerate proton particles from 70 to 250 MeV. A
linear accelerator (linac) first injects the proton accelerated up to approximately 7 MeV
into the synchrotron. The synchrotron then starts to accelerate the proton particles. The
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linac is sometimes called an “injector” or “pre-accelerator” and is, in general,
necessary for synchrotron operation. In the next section the synchrotron operation
parameters in both passive and scanning modes are discussed.
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Figure 2- 1. Overview of PTCH at the MD Anderson Cancer.
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2.2 Synchrotron operation pattern parameters: Passive scattering mode
The synchrotron employs the slow extraction method to extract and transport beams
(Tomizawa 1993, Noda 1996) to each treatment room. In this process, synchrotron
operation is governed by a sequence of phases within the magnet excitation pattern.
This conceptually comprises three distinct phases: acceleration (Tacc), flat-top (TFT),
and deceleration (Tdec). A series of these three phases composes one cycle of the
synchrotron magnet excitation pattern, which is defined as Tcyc = Tacc + TFT + Tdec in
the time domain. During each excitation cycle, proton extraction is available only
during the flat-top period, TFT; in other words, proton beam delivery is not available
during Tacc and Tdec phases in the excitation pattern, which are the main reason that the
synchrotron beam is a pulsed beam. This will be important when we consider the
efficiency of respiratory-gated techniques. The conceptual magnet excitation cycle is
shown schematically in Figure 2-2. Tacc and Tdec are fixed values (about ~ 1.05 sec
each) independent of the selected beam energy. Tcyc is a user-selected value from 2.6 –
7.1 s where, since Tacc and Tdec are fixed values, effectively TFT=Tcyc-2.1.s is selectable
parameter. The Tcyc needs to be preset prior to the start of beam delivery for each
treatment (treatment field). Once Tcyc is set, the user cannot change its value until the
completion of the beam delivery. The flat-top phase, TFT, is the phase during which the
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protons are available for extraction and delivery. Thus synchrotron-based proton beam
delivery is a pulsed beam delivery, and it is quite different from the continuous beam
delivery available from a cyclotron. The pulsed beam is called a ”spill”. The pulse
length of a spill is defined as Tspill in this study, and it has a fixed value, Tspill=0.5 sec.
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Figure 2- 2.

Time sequence of the synchrotron magnetic excitation pattern with

fixed Tcyc. Tcyc consists of an acceleration time (Tacc), a flat-top time (TFT), and a
deceleration time (Tdec). For non-gated proton beam delivery, protons are available for
delivery during the flat-top phase.
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Because both Tacc and Tdec are fixed, TFT, calculated by Tcyc= 2.1 s, is the only phase
that can be varied with the length of Tcyc and can range from 0.5 to 5.0 s. Once a given
value of Tcyc is set, the synchrotron keeps running with Tcyc governed by TFT until the
preset MU beam delivery is completed. The value of TFT is not allowed to change
during ongoing beam delivery. The deceleration phase initiates following completion
of the preset flat-top phase, TFT, or when all proton beams available to be delivered in
one operation cycle are delivered. In the case when the actual duration time of the
flat-top, TFT, is less than TFT, the remaining time [Tcyc-(Tacc+TFT+Tdec)] becomes dead
time (figure 2-3), and this dead time must pass before the next cycle begins.
The normal operation pattern described above is named “fixed Tcyc mode” in
this study. There is also another operation pattern named “variable Tcyc mode”, where
TFT is not a fixed value but a dynamic variable; it dynamically varies from the initial
default value of 0.5 s (2.7 sec for Tcyc) to 5.0 s (7.2 sec for Tcyc) . This is the major
important difference between fixed Tcyc mode and variable Tcyc mode. In variable Tcyc
mode, the duration time of TFT can dynamically change up to 5.0 s to wait for the
respiratory gate signal to be turned on. Following the beam delivery and the
deceleration phase, the next magnet excitation pattern with Tcyc starts immediately
after the end of the previous deceleration phase. Such a variable Tcyc operation pattern
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may reduce the time consuming process of waiting in the previous deceleration phase
to be completed as happens with fixed Tcyc mode.
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Figure 2- 3. Fixed Tcyc synchrotron magnet excitation pattern with short Tcyc
(TFT=0.5 s) and long Tcyc (TFT=5.0 s).
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2.3 The relationship between the Rotating Modulation Wheel (RMW) and beam
delivery
A Spread-Out Bragg Peak (SOBP) provides the possibility to deliver a uniform depth
dose to the target volume. The SOBP is a superposition of quasi-monoenergetic beams
of different intensity. In the passive scattering method, a range modulator shifts the
proton beam towards the proximal direction corresponding to a given SOBP size.
Summation of the all distributions of these modulated protons forms a uniform dose
distribution in the depth direction along the beam axis. The protons passing through
each path length in the steps are modulated in range and the SOBP is created.
Currently, the most commonly used method employs a range modulator wheel (RMW,
figure 2-4). It has a cylindrical shape of ridged steps and is composed of three
segments on the same ridge-shaped steps. The RMW rotates at the constant rate of 400
rpm. The proton beam axis is placed at a small segment of the RMW. During RMW
rotation, as the protons pass through the rotating RMW, some of protons are modulated
proximally depending on the beam path length of the corresponding step on the beam
axis at the moment. The length of the SOBP is governed by the number of steps of the
RMW the protons have passed through. The number of the steps that are needed to
create a given SOBP length is controlled by turning the proton beam on and off to just
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irradiate the corresponding steps (Figure 2-5). This method is called “Gating-off”. It is
carefully controlled to generate a uniform SOBP. However, it also reduces the number
of protons that can be delivered in a given time and thus the dose rate drops (typically
by a factor of 2).
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Figure 2- 4. Range modulator wheel (RMW).
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Figure 2- 5. Spread-Out Bragg Peak (SOBP) made with the RMW.
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2.4 Synchrotron operation pattern parameters: Beam scanning mode (spot
scanning)
Figure 2-6 shows the schematics of details about the synchrotron magnet excitation
operation in scanning mode. The main difference in scanning mode from the passively
scattering mode is that the synchrotron needs to adjust the acceleration energy for
completion of beam delivery to a target volume in one treatment session. In passively
scattering mode, the acceleration energy would never change during one session.
However the scanning beam delivery needs to change the proton acceleration energy in
order to change the depth in scan layer of the target volume from the deepest layer
(highest energy) down to the shallowest layer (lowest energy). In accordance with the
changing beam energy, the acceleration time, Tacc, is consequently supposed to change
gradually layer by layer. On the other hand, regarding the deceleration phase, for the
purpose of avoiding a hysterics of the excited magnets and maintaining the following
acceleration phase in the next cycle stable, an additional acceleration is applied to
excite the magnet up to a certain constant level, Econst, from a given energy level in the
flattop phase, EFT, prior to transition to the deceleration phase. Therefore the
re-acceleration phase (T'acc) is variable depending on the difference in energy level
between Econst and EFT. The deceleration starts at the re-accelerated energy level, Econst,
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and immediately after the end of the deceleration phase the next acceleration phase,
n+1, is initiated. Since the deceleration phase basically starts from a constant energy
level, the decelerate time, Tdec is constant. However supposing T'acc, Tdec at a given
phase, n, is expressed here by T'acc,n and Tdec,n, and also Tacc in next the phase, n+1, also
is expressed by Tacc,n+1.
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Figure 2- 6. Synchrotron magnet excitation pattern for spot scanning mode.
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The spill control (beam-on and -off) for scanning mode is also different from that for
passive scattering delivery mode. The beam delivery in passive scattering mode is off
when the spill with 0.4 MU and Tspill duration time is delivered. The completion of the
beam delivery for one treatment session is controlled with a preset dose (MU). While,
because the scanning beam delivery is mainly controlled by scan position files rather
than preset dose, following the spot file, the synchrotron is controlled to deliver as
many spot beams as possible at each energy layer (depth) within the maximum
duration time of TFT. This means that the length of TFT needs to be dynamically
variable depending on the number of spots to be delivered in each layer. The variable
Tcyc mode operates on the basis of a minimum cycle, Tcyc= 2.1 +TFT sec where the TFT
can be flexibly extended up to 5.0 sec to deliver as many spot beams as possible.
When TFT reaches 5.0 sec, the flat-top phase is immediately terminated, even
if the respiratory gate is still on and the scanning beam is being delivered, and the
deceleration sequence is sequentially started. The next acceleration sequence starts
immediately following the deceleration phase of the current Tcyc. Scanning beam
delivery at a given spot takes ts =3~4 ms, while the transition time of the scanning
beam on a single layer between spots is about tm= 3 ms at a minimum (figure 2-5), and
these numbers vary depending on the spot distance and beam energy. Thus the time for
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each spot beam delivery, tspot, takes in total tspot = ts+tm. The spill length in scanning
beam delivery mode is then calculated by tspot multiplied by the number of spots
available to be delivered. In changing the scan layer (scan depth), it takes
approximately 2.1 s to change the energy to scan the next layer, where the accelerator
needs to decelerate and move to the next acceleration phase.
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Chapter3. Specific aim 1: Passive scattering mode
A study of efficiency of passive scattering beam delivery with respiratory gated
proton beam delivery

3.1 Introduction
The main goal of this specific aim is to estimate optimal synchrotron operations for
synchrotron-based respiratory gated proton beam irradiation with passively scattered
protons. The beam delivery time, which is a part of the patient treatment time, is
estimated from a simulation study where various types of synchrotron operations run
with respiratory gating mode. From the result, the optimal synchrotron operation
parameters are determined to ensure efficient beam delivery in respiratory-gated beam
delivery mode.

3.2 Methods and Materials
3.2.1.1 Proton beam delivery parameters
In order to prepare for the simulation study, it is necessary to comprehend synchrotron
operation parameters relevant to the efficiency. The following operation parameters
and numbers were built into the simulation program.
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3.2.1.2 Synchrotron operation
Basic information of a synchrotron operation has been already explained previously in
chapter 2. The synchrotron magnetic excitation cycle, Tcyc, can be set from 2.7 – 6.5 s
prior to the start of beam delivery for each treatment. However once the Tcyc is set, it is
impossible to change its value until the beam delivery has been completed for each
treatment. The values for the acceleration phase, Tacc, and deceleration phase, Tdec, are
fixed (~ 1.1 sec each) for all synchrotron operation. During the flat top phase, TFT,
expressed by Tcyc-(Tacc+Tdec), the protons can be extracted. The value of TFT ranges
from 0.5 to 5.0 s, and TFT is always < Tcyc. Tdec usually begins following completion of
the flat-top phase. There are two modes of synchrotron operation, distinguished by
whether or not the synchrotron remains in the deceleration phase until the passage of
the remaining time in the current Tcyc.
One of these modes is named as a “fixed Tcyc” mode. If the spill has been
delivered before completion of TFT (that is, when TFT > Tsp), the phase of the magnet
excitation pattern shifts to the deceleration phase. Even after the protons are
decelerated, this phase still continues until the current Tcyc phase is completed normally
in non-magnetic excitation status. The shortest possible duration of Tcyc in this mode is
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2.7 s (Tacc = 1.1 s, Tdec = 1.1 s, and TFT = 0.5 s), and for non-gated delivery the beam
delivery time is shortest and effective dose rate is at a maximum.
The second type of operation is named as a “Variable Tcyc” mode. The initial
default values of 0.5 s for TFT and 2.7 s for Tcyc are variable during every spill. The
value of TFT can be dynamically changed from 0.5 s to 5 s to wait for the respiratory
gate signal. In addition, the next synchrotron operation cycle begins immediately
following completion of the deceleration phase of the previous synchrotron cycle. As a
result, it is expected that the variable Tcyc mode enables one to reduce time consumed
in the deceleration phase in fixed Tcyc mode.
Figure 3-1 shows a timing diagram of the respiratory gate signals and
synchrotron magnetic excitation patterns in both fixed and variable Tcyc mode. Figure
3-1(a) illustrates an example in which the fixed Tcyc values have a shorter duration time
compared to the average respiratory gate duration. In this case, there is lesser chance of
signal match between the flat top and the respiratory gate-on. This consequently leads
to a prolonged beam delivery time in respiratory-gated proton delivery. As shown in
figure 3-1(b), if the Tcyc value is longer than the average respiratory gate duration, most
of time would be wasted in the deceleration mode waiting for the completion of the
Tcyc even though the spill has been delivered in the current Tcyc. This also leads to a
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worsening of the efficiency of proton delivery under respiratory gating. Thus,
inefficiencies occur during fixed Tcyc mode, whether the duration time is long or short.
Alternatively, the variable Tcyc mode (figure 3-1c), offers the potential to achieve
more efficient beam delivery because the synchrotron does not have to spend time in
the deceleration phase until the remaining time within Tcyc is completed.
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Figure 3- 1. Timing diagram of the respiratory gate signal and synchrotron
magnet excitation patterns for fixed (short and long Tcyc) and variable Tcyc. Three
types of Tcyc are shown: (a) short Tcyc, (b) long Tcyc, and (c) variable Tcyc. (a) Tcyc is too
short to synchronize with the respiratory gate signals. (b) There is a long waiting time
following deceleration in the first spill delivery. For the second spill, TFT waits for the
respiratory gate signal within the preset duration time. This case occasionally induces
better efficiency than (a). (c) Variable Tcyc can dynamically extend TFT in every Tcyc
and wait for the next respiratory gate signal. The number of misses of the respiratory
gate signal is limited in this case.
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3.2.1.3 Uniform proton beam delivery
For each patient treatment, the beam intensity depends on the field size as well as the
beam energy. In addition, the Range Modulating Wheel (RMW) also has an influence
on the beam intensity. The RMW is a range modulator that has a combination of many
steps corresponding to different water equivalent thicknesses (figure 2-4 in the chapter
2). The small portion in the peripheral edge of the RMW is placed on the beam axis.
From this point of view, the thickness of the steps seems to be dynamically changing
during rotation of the RMW. It rotates at a high speed to create a “Spread out Bragg
Peak (SOBP)”. For example, the rotation time of the RMW is, at maximum,
approximately 50 ms for a 120 mm SOBP dose distribution. In this case, the beam
needs to cross through most of the steps in the RMW. From the beam control point of
view, the beam needs to be turned on for the entire RMW rotation. For smaller SOBP
sizes consistent with typical lung or liver tumors in this study, assuming the same
RMW is used, the beam does not need to be on for entire RMW rotation but the beam
needs to be turned on for a certain part of the RMW steps and off for other steps.
Therefore the beam “on or off” need to be controlled in binary mode, for instance 50
ms of entire beam on duration time, and the effective beam on duration time can be
less than the time resolution of the RPM data, 1/30 second.
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The spill data was set to 4 Monitor Units (MU) /1spill in this simulation. The
beam current provided by the synchrotron has a consistent intensity spill by spill. The
intensity is preserved within 5% for each spill. The effective beam on time caused by
the beam turn-on/off during a certain phase of RMW rotation was set to 30% of 50 ms.

3.2.1.4 Patient breathing data
The Real-Time Position Management (RPM) respiratory gating system (Varian
Medical Systems, Palo Alto, CA), which indirectly tracks the motion of a patient’s
chest or abdominal wall during breathing, has been used for clinical operations at MD
Anderson Cancer Center mainly for thoracic and liver patients. The RPM system
records displacement and phase data of a patient’s respiration at the rate of 30 frames
per second. Sixty-two sets of free breathing data were acquired for patients who had
been enrolled previously in lung cancer treatment studies. These breathing data sets
were used for this simulation, which provided unique respiratory gate signals for each
patient’s breathing pattern and cycle. For each patient breathing data set, the duty cycle
of various respiratory gate threshold levels, the mean respiratory motion cycle, and the
starting phase of the respiratory cycle were used in the simulation.
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Figure 3- 2. Screenshot of simulation interface. The patient data exported from RPM
is used for the simulation. It enables the user to simulate respiratory gated beam
delivery for several synchrotrons with different Tcyc. The gate threshold level is
selectable and the user can perform the simulation with different gate threshold levels.
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3.2.2 Respiratory gating simulation interface
A simulation program was developed to estimate the treatment time based on the input
of a respiratory pattern and various parameters. This software includes the accelerator
operation parameters and can perform a virtual proton beam delivery. The simulation
program can import patient breathing data exported from RPM. It enables the user to
freely set the respiratory gate threshold level (duty cycle). When the breathing signal is
below this level, a respiratory gate signal “on status” is generated. While the
accelerator patterns mentioned above sequentially runs on the simulation program at
the same time, the accelerator also sends “beam delivery ready” status in the flattop
phase. It is also possible to run multiple accelerator operation patterns with different
Tcycs and it can show the total beam delivery time for individual accelerator operation.
Figure 3-2 shows the simulation program interface. In the simulations, the user
sets the MU values as well as the respiratory gate threshold. Figure 3-3 shows the
underlying logical flowchart for the simulation interface. Using the simulation
interface the beam delivery times were estimated for several types of synchrotron
operations with different Tcyc. From this, the optimal synchrotron operation cycle, Tcyc,
for passively scattered respiratory-gated proton beam delivery were determined on the
basis of the following data analysis.
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Figure 3- 3. Concept of the simulation interface of respiratory gated beam
delivery in passively scattered mode.

42

3.2.3 Simulations
The simulations were performed for 62 patient breathing data sets to examine the
overall beam delivery time for delivery of 100 MU with respiratory gating under
different conditions of Tcyc and gate threshold levels. The efficiency was examined
with an effective dose rate, which is expressed by the prescribed dose of 100 MU
divided by the beam delivery time obtained by the simulation. A reference set based on
the ideal efficiency of the same amount of radiation (here, again 100 MU) without
respiratory gating was used for comparison. In this case, the minimum allowable Tcyc
value was 2.7 s for the passive scattering mode.

3.2.4.1 Effect of starting phase of beam delivery
Synchrotron based proton beams produce a “spill”, which is a pulsed beam in the time
domain. The duration time of an individual respiratory gate signal varies patient by
patient. Figure 3-4 shows two simulation results where all simulation conditions were
same but the synchrotron magnet pattern has started at different breathing phase by π
based on the breathing phase information. One of beam delivery time was almost two
times loner than another result just due to beam stating at different phase by π. Thus
the chance of signal matching between the synchrotron flat-top phase and respiratory
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gate signal varies strongly depending on which phase in the breathing cycle the beam
delivery or the synchrotron magnet excitation pattern is initiated. It consequently has a
great impact on the efficiency of proton beam delivery. This is called the “starting
phase effect” and was taken into account in this simulation. The patient breathing data
set exported from RPM includes phase information expressed with values between 0
and 2π (0 represents a peak of the inspiration phase, and π represents the end expiration
phase). Using this information, the same simulations were repeated for four different
phases: 0, π/2, π, 3π/2, and 2π (=0 but it means the 0 phase in the next breathing cycle).
The average value of these four simulation results is defined as the estimated beam
delivery time in this simulation.
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Figure 3- 4. Beam delivery starting phase effect. The same simulation was
performed for different phases. Simulation 2 started by π later than simulation 1. The
phase information followed RPM data. There was more signal matching between the
flat-top phase of the synchrotron and the respiratory gate signal in simulation 1, and
therefore the beam delivery time was approximately two times shorter than simulation
2. The beam delivery starting phase to a patient breathing has a great influence on the
beam delivery time.
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3.2.4.2 Effect of Tcyc duration
The respiratory-gated beam delivery for different Tcyc based synchrotron operations
were simulated. There were, in total, seven Tcycs used for the simulation: (i) fixed Tcyc
ranging from 2.7 s (the minimum permitted value) up to 6.0 s, (ii) Tcyc preset to the
average breathing cycle for each patient, and (iii) variable Tcyc (explained in section
3.2.1). The overall beam delivery time for 100 MU was examined for each setting of
Tcyc. The efficiency of gated treatment delivery and the effective dose rate were
determined for each Tcyc operation and compared to the ones with non-gated delivery.

3.2.4.3 Effect of the respiratory gating threshold level
One can define the duty cycle for respiratory-gated beam delivery by the ratio of
patient breathing under a selected gate threshold to the entire duration of patient
breathing during a beam delivery. This was computed from the RPM data for each
patient when the gate threshold level was preset. Based on each patient’s breathing
data set, the simulation accounting for the starting phase effect was repeated for three
different gate threshold levels set at the duty cycles of 10%, 20%, and 30% for each.
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3.3 Results
With respect to non-respiratory gated beam delivery, from the results of simulation it
took 1.11 min to deliver 100 MU. This resulted in an effective dose rate of 90.1
MU/min. These values were used as the reference for comparison with the 100 MU
equivalent beam delivery time with respiratory gating for each Tcyc.

3.3.1 Effect of starting phase of beam delivery
Figure 3-5 shows a histogram of the time to deliver 100 MU with respiratory gating for
a Tcyc of 2.7 s and a gate threshold level set for a 10% duty cycle (narrow gate window)
simulated with 62 patient breathing data sets. This is one example that demonstrates
the impact of starting phase on the result of beam delivery time analysis. The “0 shift”
in the legend indicates simulation results calculated at an arbitrary patient breathing
phase where this phase is regarded as the reference phase. Based on the reference
phase, the same simulation was repeated for different phases. As seen from these
graphs, the spread of the beam delivery time distribution increased as the effect of
starting phase was taken into account. The maximum beam delivery time with
respiratory gating for a Tcyc of 2,7 s was 23.2 min for a 10% duty cycle at the reference
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phase of 0, the starting phase. However, by accounting for the effect of starting phase,
the maximum beam delivery time was 43.6 min, nearly double the time for non-gating.
Similarly figure 3-6 and figure 3-7 illustrate the histograms of the 100 MU
beam delivery time with respiratory gating for a Tcyc of 2.7 s and a gate threshold level
set for 20% and 30% duty cycles. The greater the gate threshold level, the wider the
gate window became. A comparison of figures 3-5 to figures 3-6 and 3-7 showed that
the distribution of the beam delivery time in each histogram became more spread out
with a decrease in the gate threshold level from the 30% to 10% duty cycle.
Consequently, as the respiratory gate threshold level decreased, the average beam
delivery time increased. In addition, the comparison revealed that any variation in the
starting phase of beam delivery tends to have a greater influence on the beam delivery
time for the lower respiratory gating threshold level (10% duty cycle), as compared to
the higher threshold (20% and 30% duty cycle).
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Figure 3- 5. Histogram of 100 MU delivery time with respiratory gating for a Tcyc
of 2.7 s and the gate threshold level set at the 10% duty cycle. The simulation was
performed for 62 patient breathing data sets at four different starting phases from 0 to
2π.

49

16
0 Shift
1/2π Shift
π Shift
3/2π Shift
2π Shift

14
12

Number

10
8
6
4
2
0
1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

9.0

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.

Time to deliver 100 MU Eq (min)

Figure 3- 6. Histogram of 100 MU delivery time with respiratory gating for a Tcyc
of 2.7 s and the gate threshold level set at the 20% duty cycle.
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Figure 3- 7. Histogram of 100 MU delivery time with respiratory gating for a Tcyc
of 2.7 s and the gate threshold level set at the 30% duty cycle.

51

3.3.2 Effect of Tcyc duration
Figure 3-8 summarized the overall simulation results of the 100 MU beam delivery
time for each condition with non-gating and with respiratory gating for each Tcyc at
each gate threshold level using 62 breathing data sets. Each bar in figure 3-8 represents
the mean value of the distribution of beam delivery time simulation results including
the starting phase effect for each Tcyc value and gate threshold level. Examples are
shown in figures 3-5, 3-6 ad 3-7. The error bars represent the maximum and minimum
values in the distribution of the 100 MU beam delivery time for each condition
including the starting phase, which indicates the best and worst cases of the beam
delivery time for each Tcyc and gate threshold level. The mean beam delivery time for
respiratory gated beam delivery, as figure 3-8 shows, was two to ten times longer than
the beam delivery time for non-gated mode, depending on the value of Tcyc as well as
the respiratory gate threshold level. At a gate threshold level for the 10% duty cycle,
the average time to deliver 100 MU gradually decreased until the value of Tcyc reached
5.0 s, and then leveled off when Tcyc values were greater than 5.0 s. For Tcyc was set to
the average breathing cycle for each patient data set, the average beam delivery time
exceeded that when Tcyc was 4.0 s or longer (Tcyc ≥ 4.0 s). Furthermore, as seen in the
width between the maximum and minimum beam delivery times, the beam delivery
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times were widely distributed. This showed that the beam delivery time for patient
breathing cycle specific Tcyc was strongly influenced by the starting phase and/or
patient breathing type. For a variable Tcyc, the mean beam delivery time was indeed
shorter than other Tcycs and the beam delivery time was less sensitive to the starting
phase and patient breathing type. Thereby the overall simulation results indicated that
the variable Tcyc mode improved the efficiency of respiratory gated beam delivery
independent of patient breathing and starting phase effect. Since TFT in a variable Tcyc
mode can be extended until a respiratory gate is yielded and the magnet excitation
pattern can shift to the next Tcyc sequence immediately after previous deceleration
sequence, the starting phase effect was mitigated. This led to the reduction in overall
beam delivery time. One should note that the differences between the maximum and
minimum beam delivery times with Tcyc > 4.0 sec were also comparable to variable
Tcyc. These results were also considered from the efficiency point of view for each Tcyc
and each gate threshold level. The efficiency is defined as the ratio of 100 MU to the
beam delivery time, averaged over the simulation results using 62 patient breathing
data sets for each Tcyc and gate threshold level. This is called the “effective dose rate”.
The effective dose rate decreases compared with the effective dose rate in the
non-gated case, which is the ideal efficiency. Therefore the effective dose rate
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indicates how much the efficiency of beam delivery is decreased by respiratory gating
compared with the non-gating case. The overall improvement in efficiency expressed
by the effective dose rate, which shows mean values only, is shown in figure 3-9. The
variable Tcyc operation offers 1/2 through 1/4 of efficiency compared with the
non-gated beam delivery. This is the maximum efficiency regardless of the gate
threshold level.
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Figure 3- 8. Overall results of average times to deliver 100 MU over 62 patient
breathing data sets for non-gated and respiratory-gated beam delivery for each
Tcyc at each gate threshold level of 10%, 20% and 30% duty cycle, including the
starting phase effect. The bars represent the average beam delivery time and the
maximum and minimum beam delivery time are also shown as error bars for the
distributions of each simulation condition for 62 patient breathing data sets.
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Figure 3- 9. Effective dose rate for respiratory-gated beam delivery with different
values of Tcyc for each gate threshold level of duty cycle and effective dose rate for
non-gated delivery (used as a reference). The effective dose rate is defined by 100
MU divided by the average beam delivery time for each Tcyc and gate threshold level
obtained from figure 3-8.
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3.3.3 Effect of respiratory gating threshold level
One can see from figures 3-8 and 3-9 that increasing the gate threshold level from a
10% duty cycle to a 30% duty cycle led to a decrease in the average beam delivery
time, and this performed as well as increasing Tcyc did. At the lower gate threshold
level setting, as the duration time of each respiratory gate signal decreased, the chance
of signal matching between the respiratory gate signal and synchrotron flat-top phase
became lower than the higher gate threshold level. As a result, the 100 MU beam
delivery time with a lower gate threshold typically took longer than with a higher gate
threshold, resulting in a lower effective dose rate. In addition to the lower gate
threshold level, when the shortest Tcyc of 2.7 s was used, the effective dose rate
represented the worst case result (figure 3-9). As shown in figure 3-8, the error bars
became longer with the lower gate threshold level irrespective of any Tcyc pattern
because the sensitivity to the starting phase increased with a decrease in the gate
threshold level.
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3.4 Discussion
One of the major approaches for active beam delivery to a moving target due to patient
breathing is respiratory gated beam delivery. When the proton beams are delivered
during specific phases of the target motion, the effective target motion is estimated to
be small, which can reduce the internal target volume in treatment planning. This
enables one to provide greater normal tissue sparing (Chang, 2006). It also permits
dose escalation to tumors complexly surrounded by normal structures. However,
respiratory gated proton beam delivery is still much less commonly discussed in the
literature. The main objective of this chapter was to determine the optimal combination
of parameters for efficient beam delivery with respiratory gating. In order to do this, a
simulation study incorporating the synchrotron magnet excitation pattern, patient
breathing data sets, gate threshold levels and beam delivery starting phase was
performed.
First, the results of the simulation indicated that the average beam delivery
time with respiratory gating increased by a factor of 2.0 to 3.4 times for the 30% gate
threshold, 2.6 to 5.1 times for the 20% gate level and 4.3 -10.5 times for the 10% as
compared to non-gated delivery. The beam delivery time varies for each gate threshold
level depending on synchrotron operation with Tcyc. Secondly the simulation results
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showed that the variable Tcyc operation has the greatest efficiency and lowest increase
in beam delivery time for all gate threshold levels. For a 30% duty cycle gate threshold
level, the effective dose rate was 45 MU/min for the variable Tcyc mode. However for
other fixed Tcyc operations the highest efficiency was 35 MU/min. Thirdly the starting
phase of beam delivery inherently had a considerable impact on the beam delivery time.
This effect was clearly observed with short Tcyc operation ( =2.7 s) as well as Tcyc set to
the average patient breathing cycle. On the other hand, the variable Tcyc exhibited
robustness against the starting phase and the use of a higher gate threshold level for all
values of Tcyc also had less impact on the beam delivery time. The worst case of the
beam starting effect was that, for Tcyc set to the average patient breathing cycle, the
beam delivery time increased by a factor of 12 (between the minimum and maximum
beam delivery times) due entirely to the change in the starting phase of beam delivery.
Thus these are very important factors influencing the efficiency of respiratory gated
beam delivery. As several studies have demonstrated, providing audio-visual
biofeedback (George, 2006, Kini, 2003) to patients to assist in stabilizing their
breathing and synchronizing with the synchrotron operation could be one solution to
minimize the effect of such factors.
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The patient breathing data set exported from the RPM system was indirectly
obtained by monitoring the patient’s chest or abdominal surface motion using a box
placed on the patient. In most cases, it is well known that such an external surrogate
cannot reflect accurate internal tumor motion (AAPM Report of Task Group 76, 2006).
Tsunashima et al (2004) reported that the there are phase differences on the order of
0.0 ~0.3 s between external respiratory motion and internal tumor motion in the liver,
esophagus and lung. Thus, if one were to evaluate gated beam delivery to the moving
target from a dosimetric point of view, it might have been controversial to use the
external surrogate based patient breathing information. However the objective of the
simulation study is to estimate the beam delivery time. The important information used
in the simulation study is time domain information. The simulation result would not be
influenced by how the accuracy the external surrogate used would express the target
location, the phase difference between external surrogate and the target motion, even if
its amount is significant, has no impact on the beam delivery time as long as an
external surrogate is used for the respiratory gating system.
The beam delivery time of respiratory gated beam delivery was estimated by
simulation, and its efficiency was also discussed for the passively scattered proton
delivery mode only in this study. Further study is also required to ensure respiratory
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gated proton beam delivery in passive scattered mode from the accuracy point of view
with the different Tcyc operations investigated in this study. A similar study for
respiratory gated proton beam delivery for spot (pencil beam) scanning beams will be
an important subject in the further development of proton therapy. It may offer further
potential to improve dose conformity on the target and increase normal tissue sparing.
This could facilitate dose escalation to tumors that are surrounded by critical normal
tissues, which would not have been otherwise possible.

3.5 Conclusions
The simulation study demonstrated the feasibility of respiratory gated beam delivery of
synchrotron-based pulsed proton irradiation with minimal increase in beam delivery
time. The results in this study indicate that a variable Tcyc mode of operation offers the
greatest efficiency and is impacted less by patient breathing and the beam starting
phase effect for respiratory gated delivery of pulsed proton irradiation.
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Chapter 4. Specific aim 1: Beam scanning
A study of efficiency of spot scanning beam delivery with respiratory gated proton
beam delivery

4.1 Introduction
The purpose of this study is to perform a simulation study similar to that done for
passive scattering mode in previous chapter in order to evaluate the efficiency of
synchrotron-based respiratory gated beam delivery for spot scanning mode. The
simulation program is modified for scanning beam operation mode where all
accelerator operation parameters for scanning beam delivery mode were employed. In
addition, since it is expected that the scanning beam delivery time depends on the scan
volume, scan volume information was taken into account in this study. The simulations
are based on various scanning treatment plans using real lung patient CT data. The
treatment plan generates a scanning file including the scan position and its beam
intensity for each scanning volume. The scan position pattern is run with a variety of
patient breathing motion files in the simulation, and the beam delivery time and its
efficiency under various respiratory gate levels are evaluated. The simulation results
could be useful when considering the feasibility of respiratory-gated proton scanning
treatment.

62

4.2 Methods and Materials
As already discussed in chapter 2, the synchrotron operation and the structure of a spill
in spot scanning mode are different from those in passive scattering mode. Some of the
synchrotron operation parameters employed for scanning mode play a very important
role in the simulation study. First, the synchrotron operation for scanning mode is
introduced in this section. Second, the patient breathing pattern and scanning plan used
in the simulation study is explained, and finally the procedure for simulation and
analysis is described.

4.2.1 Characteristics of synchrotron operation for spot scanning mode
As briefly mentioned in the introduction, the synchrotron magnetic excitation pattern
runs in the variable Tcyc operation mode. This is currently the only mode available for
scanning beams in Gantry 3 at PTCH. Furthermore, in previous chapter, the variable
Tcyc mode was demonstrated to be the most efficient beam delivery operation for
respiratory gating mode for passively scattered beams. Variable Tcyc operation is also
less influenced by the starting phase of the beam delivery in terms of the patient
breathing phase (discussed in chapter 3). Therefore the simulation study was
performed only for the evaluation of the variable Tcyc operation with respiratory gating
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in scanning beam operation. Since the synchrotron magnetic excitation pattern for
scanning mode is somewhat different from passive scattering mode, the synchrotron
operation and its parameters used in the simulation program for scanning mode are
introduced in the following session.

4.2.1.1 Synchrotron operation pattern and parameters for simulation
The synchrotron magnet excitation pattern for scanning mode, as explained in the
chapter 2, is quite complicated. The simulation program for this study simplified the
synchrotron operation patterns with identical accuracy. Figure 4-1(a) shows the
schematics of actual synchrotron magnet excitation operation in scanning mode.
According to the specifications for synchrotron operation in scanning mode, the
duration time from re-acceleration to the end of the next acceleration phase, T′acc,n +
T′dce,n + Tacc,n+1, is a constant value regardless of energy. Therefore we have defined a
new expression for the deceleration phase, T′dec,n for convenience as

T′dec,n≡T′acc,n+Tdec,n

And therefore,
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T′dec,n+Tacc,n+1 ≈ 2.1 sec (constant)

by which the simplified accelerator operation pattern is also regarded as the classic
acceleration pattern used in the passive scattering mode represented in figure 4-1(b). In
addition, it is possible to replace the summed value of T′dec, n+Tacc, n+1 with a constant
value, 2.1 sec. This enables one to simplify the accelerator operation pattern in our
simulation study so that the acceleration pattern is expressed as the classical
accelerator patterns. However it should be noted that, since there is a difference
between T′dec,n, and Tdec,n, the T′dec,n is used in our simulation.
Regarding other parameters required for the simulation, there is a 180 ms
delay time from beam-on (extraction) ready signal to actual beam irradiation in the
variable Tcyc mode. The synchrotron with the variable Tcyc mode has a function of
dynamically changing the flat top phase to wait for the signal coming from the
respiratory gating system. The available waiting duration time ranges from 0 ~ 200 ms.
The spill length, Tsp, ranges from 0 ~ 5000 ms but the effective spill length is the
number subtracted from the available waiting time. If all the spot beams are delivered
on a given scan layer while the respiratory gate is on and the synchrotron is in ready
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status or in the case that a respiratory gate signal turns off while the beam is being
delivered (the synchrotron ready status), the deceleration phase is forced to start as
soon as the spot being delivered at the moment has been completed. The mechanical
delay time of the transition to deceleration phase is consequently the last spot delivery
time at each spill. There may be an uncertainty arising in beam delivery measurement.
However this can be ignored when accounting for the spot delivery time, as discussed
in the next chapter.
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Figure 4- 1. Illustration of synchrotron magnet excitation pattern. The solid line
expresses the higher energy acceleration pattern and the dashed line represents the
lower energy acceleration pattern.
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4.2.1.2 Spot scanning beam delivery
The coordinate system of the scanning data is that the y-axis is defined as the patient
longitudinal direction and x is perpendicular to the y axis, which is not always the
patient lateral direction because the direction changes with gantry angle. The scanning
beam delivery time consists of two parts: shooting one spot beam and moving on to the
next spot position. The former takes approximately 4 ms to produce the maximum spot
dose. The spot position transition time is parameterized with the distance from one
point (xs,i, ys,i) to next position (xi+1,yi+1) and the beam energy. Currently the minimum
spot spacing is set to 4 mm for each direction and the spot transition takes
approximately 3.2 ms to move to 4 mm distance in each direction. Table 4-1 shows
experimental data for spot transition time for the x- and y-directions for a proton
energy of 219.3 MeV.
The spot position transition time is different in the x- and y-directions for each.
It also varies depending on spot spacing (dx, dy in distance) and spot energy (E). The
spot transition time for each condition is interpolated from the data in table 1. There
are two sets of formulas for computing the spot transition time for each direction:

68

When dx > 0.4 cm and dy < 2.0 cm,

tx=

1
5.3 − 3.2
2
2.0 − 0.4 E + E p E

219.32 + E p * 219.3 * dx + b

ty=

1
3.7 − 3.2
2.0 − 0.4 E 2 + E p E

219.32 + E p * 219.3 * dy + b

When dx > 2.0 cm and dy < 30.0 cm,

tx=

33.6 − 5.3
1
2
30 − 2
E + EpE

219.32 + E p * 219.3 * dx + b

ty=

17.0 − 3.7
1
30 − 2
E2 + EpE

219.32 + E p * 219.3 * dy + b

where
b: variable depending on E
Ep: rest energy of a proton (=938.3MeV)

When the spot moves to an oblique position, the spot transition occurs in the x- and
y-directions simultaneously; therefore the total transition time, T, takes the maximum
value from either,
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Tspot=max (tx, ty)

and Tspot is calculated for every spot in the simulation.
The spot information used in the simulation includes the spot position (x- and
y-direction on the beams eye view plane) and scan energy (layer) and beam weight.
These are included in the spot file exported from treatment planning system used
clinically (Eclipse, Varian®). Although the spot size and dose, with ranges 0.04 ~
0.005 MU, may be very important to configure the patient dose distribution and
evaluate the dosimetric impact, the geometrical size of the spot beam was not used and
does not influence the beam delivery time. It was therefore not discussed in this study.
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Distance [cm] Transition Time [ms]
x
Y
0.4
3.2
3.2
2
5.3
3.7
30
33.6
17.0
Table 4- 1. Experimental data the spot transition time for a proton energy of 219.3
MeV.
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4.2.2 Spot scanning plan file
The DICOMRT file includes a scan plan including the number of control points (CPs),
spot position, spot weighting and spot energy for each CP. The scan plan file for each
treatment session is connected to the beam delivery time because the beam delivery
time is in principle governed by the number of spots. Some spot locations are
duplicated, which indicates a re-scanning process, meaning that rescanning is
performed following the original scan. Rescanning is currently required because the
maximum dose per spot is limited to 0.04 MU/spot. If more dose is needed at a given
position, repainting is needed. The total number of the spots is a very important factor
in the beam delivery time estimation because if the number of spots is too great, the
spot beam delivery of one CP would be unable to be done within the maximum Tcyc,
which would cause the next beam delivery sequence to commence after waiting for the
Tdec+Tacc =2.1 s interval. Each layer is additionally parameterized by depth (or
effectively associated with a specific proton energy). When changing the scan layer,
the synchrotron needs to take a sequence of declaration and acceleration. The sequence
of energy change would be potentially a main cause of time consumption in beam
delivery. It is associated with the number of CPs, and also the number CPs is
determined by the target shape in a given beam direction. The scanning beam delivery
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simulation is should be applied to many kinds of target volumes and shapes even in
same volume of targets.

4.2.3 Scan target volume
In this simulation study, the scanning beam delivery run following the scan pattern
files were made from intensity modulated proton therapy plans. The scan target
volumes were made based on the planning target volumes for each treatment plan. The
10 IMPT treatment plans including 38 sessions (beam angles) were used for the
simulation. Table 4-2 summarizes the scan target volume. Scan target volumes for each
patient were calculated from the scan position files. These plans were made using
Eclipse version (8.1.8 Varian®) for research purposes (Zhang X, 2010). The target
volumes accounted for target motion using a 4DCT data set; in other words, since the
target volumes were made based on the average CT data set (Underberg R W M, 2005),
the scan volumes were consequently different from the true target volume that would
be used in respiratory gating mode. Although these plans were not originally created
for the respiratory gating beam delivery, it is would not be a concern because the aim
of this study was focused on investigating the relationship between the variety of scan
target volumes and beam delivery time. For this reason, the simulation study needed as
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many types of scan target volumes as possible for measuring the scanning beam
delivery time. Further, because the optimization process in the treatment planning
system does not include a factor accounting for either motion uncertainty or the
respiratory gating, it does not also matter what kind of scan target we use.
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Scan volume information
Median

minimum

maximum

Volume [cm3]

315.4

85.5

932.9

Number of layers

55

46

150

Number of Spots

2189

272

5748

Table 4- 2. Statistics of the scanning target volumes used in the scanning beam
simulation study. The data includes 38 different beam angles for 10 patient plans.
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4.2.4 Respiratory motion data sets
The Real-Time Position Management (RPM) respiratory gating system (Varian
Medical Systems, Palo Alto, CA) was used in this study. The RPM system tracks the
displacement of a patient’s external morphological features and records displacement
and phase data for patient breathing at the rate of 30 data points per second. The
synchrotron operation parameters and spot delivery time are recorded in ms order in
the program, thus the RPM data were also converted into ms order through
interpolation. Ten free-breathing data sets acquired when patients had been previously
enrolled in treatment for lung cancer were used for the simulation.

4.2.5 Respiratory gating simulation program
Figure 4-3 shows the in-house simulation software interface that enables virtual
simulation on the scanning treatment with or without the respiratory gating (selectable).
It can import a scanning treatment plan output made from Eclipse DICOMRT file
(Varian), which includes scan positions, scan energies, and spot weights for each scan
layer, which is the control point (CP) for each treatment session distinguished by
gantry angle. The software can also import patient breathing trace data exported from
RPM in respiratory gating simulation mode, and we can arbitrarily set the respiratory
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gate threshold level. As the simulation begins, the patient breathing data read from the
patient breathing file and the synchrotron magnetic excitation pattern with the variable
Tcyc mode run simultaneously. When the respiratory gate is on and the synchrotron is
in flattop phase, ready for beam delivery, the spot beam delivery starts following the
scan plan created with Eclipse. The scan beam delivery is finished when the spot beam
has been delivered to all scanning positions. The simulation interface expresses the
signal interaction between patient breathing and synchrotron and beam delivery
operations as if we are looking at signal outputs on an oscilloscope.

77

Figure 4- 2. Screenshot of the in-house simulation software interface for
respiratory gated scanning beam delivery. It enables the user to import a spot file
exported from treatment planning (Eclipse Varian Ⓡ) and a patient breathing data set
from RPM (Varian Ⓡ). The user can select the respiration gate threshold level for each
simulation.
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4.2.6 Simulation study
The simulation was performed using the software described above. From the
simulation results the beam delivery time was analyzed and the variation efficiency of
scanning beam delivery due to the interaction between scanning plans and patient
breathing patterns was observed, and the results were compared to those for the
non-respiratory gated scanning technique.

4.2.7 Simulation of scanning beam delivery time and analysis
The imported patient breathing data sets and the synchrotron magnet excitation
patterns were run on the software at the same time, and respiration gate signal was also
simultaneously generated based on a preset gate threshold level. When the signal
matching between the respiratory gate signal and the flat-top phase of synchrotron
magnet excitation pattern occurs, the spot beam is delivered following the order
specified in the CP file. The simulation software measured the beam delivery times for
each control point file. This comprised one session of simulation to measure the beam
delivery time for each CP file (each treatment field) with one breathing data set and a
certain gate threshold level. This was repeated for different breathing data sets and gate
threshold levels and estimated the overall beam delivery time of respiratory gated spot
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beam delivery for each treatment field (each CP file). The treatment efficiency and
effective dose rate were also calculated.
The efficiency of the passive scattering beam delivery mode discussed in the
previous chapter was evaluated with 100 MU equivalent beam delivery as a reference
for measuring the dose delivery time. It followed the beam delivery control system for
the passive scattering mode. As the delivered dose met the preset dose of 100 MU, the
beam delivery for each treatment session (at each gantry angle) was completed and
also defined as an end of the given treatment session. The completion of beam delivery
for scanning mode is quite different from passive scattering mode, however. The
completion of beam delivery is recognized in the control system when the scan pattern
following a scan file (DICOMRT exported from Eclipse) is completed. Thus, it does
not use a certain preset dose as the main beam delivery control parameter. Therefore,
in the scanning simulation study, the beam delivery times obtained from each
simulation were not based on a consistent number of MUs, and thus it is not as easy to
compare the dose delivery times for the scanning mode as for the passive scattering
mode. This is why we mainly focused on the relationship between the effective dose
rate and target volume or shape for the comparison of efficiencies.
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4.2.8 Starting phase effect
The synchrotron-based proton beam, that is spill, has a pulsed beam which is neither a
continuous beam or always available to be delivered. Therefore the proton spill is
yielded only when the respiratory gate signal is turned on during the flat-top phase in
the synchrotron magnet excitation pattern. For this reason, in chapter 3, the effect of
the starting phase had a significant impact on the beam delivery time in accordance
with the choice of Tcyc. In spot scanning mode, the variable Tcyc mode is employed,
and is most efficient operation, being robust against to the effect of starting.
Concerning variable Tcyc operation, its unique advantage is that the synchrotron can
wait for the respiratory gate signal coming for 5.0 s at maximum. It was demonstrated
in the previous chapter that the starting phase effect is effectively reduced when using
the variable Tcyc operation, and the error that arose in the results of the beam delivery
time were caused by the variations in patient breathing patterns rather than the starting
phase. Therefore the simulation study did not take the starting phase effect into account.
The focus in this study was on the variability of scan beam delivery caused by
variability of the patient breathing pattern and the scan target volumes and shapes.
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4.2.9 Effect of respiratory gate threshold level
Respiratory gating was applied in exhale phase under regular patient breathing
conditions. From each set of patient breathing data, the simulation for respiratory
gating beam delivery to each treatment field (scan volume) was repeated for three
exhalation threshold levels of 10%, 20%, and 30% duty cycles.

4.3 Results
The scan beam delivery times were calculated from simulation. First the relationship
between the time to the cover the target volume with the scanning beam, the number of
spots and the number of control points (scan layers) was investigated. Secondly the
efficiency analysis using MU was discussed.

4.3.1 Scanning beam delivery time
Figure 4-3 shows the relationship between the scanning beam delivery time with
respiratory gating and the number of the layers (control point, figure 4-3 (a)), the
number of spots (figure 4-3 (b)) and the scan target volume (figure 4-3 (c)). The results
of simulation for the beam delivery time without respiratory gating were also shown in
the graphs for comparison. Each plot represents the averaged values from one session
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running with 10 patient breathing data sets. The graphs showed that the scanning beam
delivery time with respiratory gating is dependent on the scan volume and the number
of layers, and the relation depended consistently on the gate threshold. The worst case
was approximately 36 min needed for beam delivery to a 906.2 cm3 volume with a
10% duty cycle. For the beam delivery times with 30% and 20% duty cycles, these
became 2.4 and 3.6 times longer on average than the reference beam delivery time
without gating. On the other hand, the beam delivery time with a 10 % duty cycle gate
level was 9.0 times longer on average than the reference, and the delivery times varied
significantly with the scan volume compared with those with 30% and 20% duty
cycles.
Figure 4-3 (d) shows a summery of the correlation coefficients between the beam
delivery time and factors in each graph for each gate threshold level. Comparing these,
the beam delivery time had stronger relationship with the number of the control points
and spots than the scan volume. Without gated scanning beam delivery, the number of
control points has much stronger correlation with the beam delivery time than other
two factors, which indicated that the beam delivery time was governed by the number
of control points. For the respiratory gating mode, the beam delivery time was
governed by the number of spots when the gate threshold level was high; however as
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the gate level was lowered, the beam delivery time become much more correlated with
the number of control potions.
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Figure 4- 3. Scanning beam delivery time vs. target volume, number of control
points and number of spots to be delivered.
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4.3.2 Effective dose rate (MU/min) analysis
The beam delivery time theoretically increases with the size of scanning volume and
its delivered dose. Therefore the simulation results need to be normalized with either of
them for comparison. Figure 4-4(a) shows the relationship between the effective dose
rate (MU/min) and the scan volume. The effective MU/min was calculated by the
prescribed dose in MU divided by the beam delivery time. The results of the graph
indicated that there was no significant difference in the effective MU/min over the scan
volumes. As shown in figure 4-3 (c), the correlation between the scan beam delivery
time and volume is weaker than the scan volume and CP. Figure 4-4 (a) also showed
that the efficiency of respiratory gated beam delivery expressed with the effective MU
was consistent. It was clearly seen in figure 4-4(b), which represents the histogram of
the effective MU/min shown in figure 4-3(a). The average effective dose rate was
34.2±18.8 (MU/min) for the non-gated scanning beam delivery where the spot position
scan patterns were run without respiratory gating. Ideally, the beam efficiency would
be as close to this value as possible for scanning beam delivery treatment with
respiratory gating. With gating, the effective MU/min was however reduced to
13.0±3.4, 8.6±2.2 and 3.3±0.7 MU/min for 30%, 20% and 10% duty cycles
respectively. The beam efficiency dropped down to 2.3 ~ 10.3 times with respiratory
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gating. The graph also showed that as the gate level was lowered (a narrow gate
window), the standard deviations of the effective MU/min for each gate level
decreased. The effective MU/min seemed to become independent of the scan plan and
patient breathing and converged to a certain value.
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Figure 4- 4. Result of the effective MU/min for 10 scanning plans (total beam 33
angles).
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4.4 Discussion
The results of simulation showed that the beam delivery time with the respiratory
gating was more dependent on the number of control points (CPs) than the scan
volume. The efficiency decreased 2.3 ~ 10.3 times compared to non-gating beam
delivery.
For scanning beam delivery without respiratory gating, in most case, all spots
of an identical scan energy layer are delivered within one cycle of synchrotron
operation Tcyc as long as the spill length, Tspill, does not exceed the maximum duration
time of 5.0 s. This is an ideal situation and the best efficiency case scenario for
scanning beam delivery. In this case, according to the simulation results, only
approximately 30% in the entire beam delivery time for each session is spent for actual
beam delivery, that is calculated by integration of all values of Tspill. The remaining
70% was spent for the acceleration and deceleration of the synchrotron, the sum of
which is Tacc+Tdec=2.1 s for each session. As the number of CPs increases, the number
of Tacc+Tdec=2.1 s cycles consequently increases because, when the energy layer is
changed corresponding to the changing CP, the synchrotron needs to have deceleration
and acceleration phase every single time. Since the time for scanning beam delivery
without gating is mainly spent for energy changes (Tacc+Tdec=2.1), as shown in
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figure4-3(d) the beam delivery time has of course good correlation with the number of
CPs. The number of CP has low correlation with the target volume. For example,
assuming that a scan plan is made for a given target with an oval shape, the number of
CPs made in the longitudinal direction is greater than the one made in the direction
perpendicular to the original one. The difference in the number of CPs is connected to
the number of acceleration and deceleration phases (2.1 s), which consequently has a
great effects on the beam delivery time even for the same target volume. This is not
taken into account in the relationship between the scan volume and the beam delivery
time.
This explains the poor correlation seen in figure 4-4(c). The time consumption
for energy change may be a synchrotron-specific issue. As discussed in the literature, it
is in principal not a big issue for one type of cyclotron (Pedroni, 1995); however, a
somewhat there is a similar issue associated with machine specification was reported
for another type of cyclotron in which energy changes were reported to require 2~ 10 s
(Paganetti, 2005 and Lu, 2007).
On the other hand, for beam delivery time with respiratory gating, the total
beam delivery time becomes longer depending on the gate threshold. The main reason
is the mismatch between the respiratory gate-on status and the flattop phase. When
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such a mismatch occurs, the beam is not delivered and which is time wasting while the
synchrotron is waiting for the respiratory gate signal to be on, but when it is not on, the
synchrotron is forced to decelerate and move to next acceleration. This considerably
affects the beam delivery time and efficiency. The total spill is basically nearly
consistent whether the respiratory gate is used or not. The time consumption due to
energy change, which was main cause of the beam delivery without gating, was still
the main contribution to the beam delivery time with respect to 30% duty cycle. It was
5 times the value of Tspill and to the other major contribution due to gate signal
mismatching was 2.3 times Tspill in the total beam delivery time. However, for the
beam delivery for a 20% duty cycle, these ratios were 5.6 and 5.3 times Tspill for each,
and finally 7.9 and 11.1 times Tspill for a 10% duty cycle. The contribution to the time
consumption due to sum of Tacc+Tdec increased for low gate thresholds because the
width of each respiratory gate signal is narrower, limiting the time for beam delivery
and requiring the next Tacc+Tdec sequence to complete the remaining beam delivery.
Therefore there is a greater number of spills needed to complete the same beam
delivery. For this reason the correlation between the number of CPs and beam delivery
time improved. However, the time consumption due to the signal mismatch had a
greater impact on the beam delivery time than the time consumption of Tacc+Tdec
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repetition for the lower gate threshold level. As mentioned above, the signal mismatch
had significantly less impact on beam delivery for 30% duty cycle (5 to 2.3 compared
to Tspill); however, this becomes nearly equivalent for a 20% duty cycle, and for a 10%
duty cycle signal mismatch becomes the main reason for time consumption over the
Tacc+Tdec repetition (7.9 to 11.1).
As shown in figure 4-4(b), the effective MUs without gating beam delivery
were naturally higher and diverging for each scan plan compared to the case with
respiratory gating. The effective MU/mins obtained without gating are strongly
depending on each scan plan including the number of CPs and the prescribed dose
(MU) for each plan. This is why the effective MU/mins were diverging. On the other
hand, for the effective MU/min with gating, there is another factor to limit the spill
length, which is the gate signal from respiratory gating system. For a lower gate
threshold level, the width of the respiratory gate signal (duration time) becomes short
and nearly consistent every gate signal regardless of the patient breathing pattern. For
example, the average duration times of respiratory gate signal over the 10 patient
breathing traces used in this study were 1.2±0.5, 0.8±0.3 and 0.5±0.2 s for the 30%,
20% and 10% duty cycle gate thresholds, respectively. This shows that the number of
deliverable spots, that is spill time, are very limited by these numbers, and the spill
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time consequently becomes nearly independent of the patient breathing pattern.
However, it should be noted that the lower gate threshold takes very long time to
deliver all spots shown in figure 4-3.
As a comparison, the effective MU/min for respiratory gated beam delivery in
passive scattering mode obtained similarly in previous chapter were 43.5 MU/min,
33.3 MU/min and 20.0 MU/min for 30%, 20% and 10% duty cycles, respectively.
Strictly speaking, it is difficult to compare the effective MU/min between the passive
and scanning beam delivery with respiratory gating because the basic concept of beam
delivery is quite different. However, the differences in the numbers have important
meanings and may be very helpful to estimate the treatment time for respiratory gated
scanning beam delivery.
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4.5 Conclusions
Delivery of pulsed scanning beam proton therapy with respiratory gating is less
efficient than passively-scattered proton irradiation. The results of this study quantified
the reduction in efficiency for respiratory-gated scanning beam delivery. It is certainly
true that a lower gate threshold greatly increases the beam delivery time. However,
these results suggest very important information when making a decision of what gate
level would be reasonable considering the balance between dosimetric quality and
efficiency.
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Chapter 5. Specific aim 2: Passive scattering mode
Assess the accuracy of dose delivery in respiratory-gated proton therapy in
passively scattered beam delivery

5.1 Introduction
A spill in synchrotron-based respiratory gated delivery can be delivered only when the
respiratory gating system turns on the gate signal during the flat-top phase of the
synchrotron. A mismatch between the respiratory gate-on signal and the flat-top phase
can worsen the efficiency in respiratory-gated proton delivery. The impact on the
efficiencies due to the synchrotron operation cycle, Tcyc, have been investigated in
specific aim 1: passive scattering mode (Tsunashima 2008). In addition to the
inefficiencies, especially for the passively scattered beam delivery mode, the pulse
length of the spill is currently fixed at 0.5 s/spill. If the duration time of a breathing
phase under the gate threshold and ready for the gate-on is longer than the spill length,
the spill is delivered at some time during the gate-on phase with the respiratory gating
system. This is a stochastic event where the spill is almost randomly delivered within
the patient breathing phase under the threshold level.
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In accordance with this, it is hypothesized that because proton beams extracted from a
synchrotron are pulsed-proton beams the quality of proton beam delivery to the
moving target with respiratory gating has an uncertainty pulse-by-pulse. Such
uncertainties could be dependent on the synchrotron operation cycles, Tcyc, discussed
in chapter 3. However, as already stated in chapter 3, the feasibility of the respiratory
gated beam delivery from the quality point of view has not been studied in detail.
Therefore, the purpose of specific aim 2 is to quantify and evaluate the uncertainties of
the synchrotron-based respiratory gated proton beam delivery.
This chapter focuses on the passive scattering technique and the investigation
of the uncertainty of beam delivery with respiratory gating from the viewpoint of the
patient’s breathing signal. The simulations developed in specific aim 1 were extended
to analyze the precision of respiratory gated proton beam delivery for different gate
threshold levels and synchrotron Tcyc durations using different types of patient
breathing patterns.
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5.2 Methods and Materials
In specific aim 1, in-house simulation software for respiratory gating was developed to
estimate the efficiency of respiratory gated proton delivery (Tsunashima et al 2008). In
order to examine the precision of respiratory gated proton delivery the software used in
chapter 3 has been modified to record the beam delivery in the time domain.

5.2.1 Synchrotron operation patterns and patient breathing data sets
The synchrotron magnet excitation patterns of the PROBEAT proton beam system
with fixed and variable Tcyc operations were discussed in chapters 2 and 3. The
simulation was implemented for three different synchrotron magnet excitation
operations with Tcycs. First, Tcyc was fixed to 2.7 – 4.0 s with which the Tcyc is too short
to synchronize with the respiratory gate signal (figure 5-1(a)). Secondly Tcyc was fixed
conversely too long (5.0 -6.0 s,), with which the synchrotron can synchronize with the
respiration gate; however, once beam has been delivered, it is forced to spend a long
wait time for completion of Tcyc operation. This leads to diminished efficiency (figure
5-1(b)). Thirdly the variable Tcyc (figure 5-3(a)) has the most efficient operation pattern.
Further details on the variable Tcyc were discussed in chapter 3, specific aim 1. The
simulation with different types of Tcyc synchrotron operations was performed for 100
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MU beam delivery, different gate threshold levels and 70 breathing data sets exported
from RPM (Varian Medical Systems, Palo Alto, CA). The details of Tcyc, gate
threshold levels and other conditions used in the simulation were described in the
previous chapter.
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Figure 5- 1. Examples of beam delivery for fixed Tcyc having (a) short (Tcyc=2.7 s)
and (b) long (Tcyc=5.0 s) operation and (c) variable Tcyc operation.
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5.2.2 The precision of respiratory gated proton delivery
Figure 5-2 (a) shows an example of the simulation result. The RPM amplitude
information, synchrotron magnet pattern and spill delivery were expressed in time
domain (t). Each spill delivery was represented on the bottom of the graph and
simultaneously these points were superimposed on the breathing trace (the blanked
boxes plotted in figure 5-2(a)). For data analysis, each beam delivery point was
assigned to each corresponding amplitude, xk (k=0,1,2…. ), of a random variable X
with probability P(X=xk). This subsequently represented the probability density
function (PDF) of the beam delivery points for respiratory gated beam delivery (figure
5-2 (b), (c)). For figure 5-2 (b), since the random variable X originally represented the
patient breathing signal from the RPM system in the amplitude domain, the PDF,
denoted by P(X), represented when or on which amplitude based patient breathing
trace the spills were most probably delivered with respiratory gating. With respiratory
gating, all beam delivery points obtained from the simulations, xｋ, were distributed
under the gate threshold level. Thus, the PDF of the beam delivery points were
expressed by the probability distribution f(xk) (figure 5-2 (c)):
P ( X = xk ) = f ( xk )

(k = 0,1,2......)

(1)

xk =0 = xGateThreshold
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At first the PDF of all the data points of the breathing trace under the gating threshold
level was calculated. This represents the overall residual position uncertainty during
the respiratory gated beam delivery. Assuming an accelerator provides a direct current
beam delivery such as a cyclotron, the residual position uncertainty could represent the
residual motions during the direct current beam delivery. This is useful as a reference
when comparing synchrotron-based respiratory gating to cyclotron-based respiratory
gating. Figure 5-2 (d) is the result of summing each plot from the gate threshold level,
xGateThreshold, on the PDF. This is defined as cumulative distribution function (CDF),
denoted by Φ(x), which was expressed as follows:

i

Φ ( x) = P( X ≤ x) = ∑ f ( xk )

(2)

k =0

xk = i = x

and this process was used to determine a metric to calculate the uncertainty of
respiratory gated proton delivery. In figure 5-2(d) there is a point, denoted by x’, set on
the CDF at which approximately 95% of the total number of beam delivery points have
been reached.
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This is expressed by the following formula:

CDF95= Φ ( x' ) = P( X < x' )

(3)

R95= x'− xGateThreshold

Here the relative distance from the gate threshold to x’ is defined as R95. The R95 is a
variable depending on the Tcyc operation, respiratory gate threshold level and starting
phase of beam delivery. In order to take these into account, one session of a simulation
was performed for several conditions with these parameters, and each simulation was
repeated using 70 breathing data sets. From the simulation results the CDF and R95 for
each condition were statistically analyzed.
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Figure 5- 2. Procedure to create the PDF and CDF from the simulation result. (a)
is the simulation result for Tcyc=2.7 s and a 30% DC as the gate threshold level. The
spill delivery was expressed with unfilled square symbols plotted on the breathing
trace below the gate threshold level (shadowed area in (a)). (b) and (c) show the
probability density function of the symbols (PDF). (d) shows the cumulative density
function (CDF) calculated by summing each plot from (c).
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R95 represents the most probable phase of spill delivery from the viewpoint of the
patient breathing trace. For example, if R95 is very close to the gate threshold (R95≈0),
it means that most of the spills are probably delivered just after the breathing trace
drops below the gate threshold rather than in the true end-expiration phase. Conversely,
if R95 is farther from the gate threshold level, most spills are delivered almost
randomly under the gate level as shown in figure 5-2(a). Therefore, in the former case,
the phase of the spill delivery is reproducible yet has a systematic uncertainty near the
gate threshold level. The systematic uncertainty follows the PDF obtained from the
simulations for each patient breathing pattern. The latter shows the spill delivery has a
random uncertainty or lower reproducibility under the gate threshold. The uncertainties
discussed in this simulation study indicate the reproducibility of the beam delivery
phase, and are expressed with the terms “precision” or “reproducibility” in the
following analysis.

5.2.3 Parameters used for the respiratory gating beam delivery simulations
The simulation study undertaken accounted for the following three effects parameters:
starting phase, Tcyc, and respiratory gate threshold.
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5.2.3.1 Effect of start phase of beam delivery
The simulation result could change depending on when the synchrotron magnet
excitation pattern or the first beam delivery is initiated from the patient breathing
viewpoint. This was observed in chapter 3. The precision of synchrotron-based pulsed
proton beam delivery may be also influenced by the starting phase of beam delivery as
well as the efficiency (Tsunashima 2008). In order to account for this, by using the
phase information obtained from each patient breathing data set exported from the
RPM system, the same simulation was repeated for five different starting phase values;
0, π/2, π, 3π/2 and 2π. From this, the five values of R95 were calculated for each
starting phase. Among the R95s the average and standard deviation (σ) were calculated
for each simulation condition and set of patient breathing data.

5.2.3.2 Effect of synchrotron operation cycle Tcyc
The bending magnet excitation pattern of the synchrotron was simulated using various
Tcyc settings: (i) fixed Tcyc settings from the minimum of 2.7, to 3.0, 4.0, 5.0 and 6.0 s,
(ii) a fixed Tcyc approximately equal to the patient’s average respiratory cycle (which
was defined as a patient specific Tcyc), and (iii) the variable Tcyc operation mode shown
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in figure 3-1 (Tsunashima 2008). For each of these settings, the R95 values were
determined and analyzed.

5.2.3.3 Effect of the respiratory gate threshold level
The simulation with a given Tcyc for each breathing data set was repeated for three
different gate threshold levels with 10%, 20%, and 30% duty cycles in the exhalation
phase. The definition of duty cycle (DC) for respiratory gated beam delivery was
previously explained in section 3.2.4.3.As with the other effects discussed earlier, the
average R95 and its standard deviations were determined for each simulation condition.
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5.3 Results
The overview of one simulation result for all Tcycs is shown in figure 5-3. It represents
100 MU equivalent beam delivery simulations for an unstable breathing pattern for
seven different values of Tcyc, a 30% duty cycle and a starting phase of 0 (discussed in
chapter 3). The entire breathing traces were shown for the result of Tcyc=2.7s only. The
breathing traces just under the gate threshold were shown in gray color from the result
of Tcyc=3.0 s. The green lines were synchrotron magnet excitation pattern operating for
each Tcyc. The spill delivery was expressed as a certain value in each color inside of
each synchrotron operation pattern. The spill delivery points were also projected on the
breathing traces with colored structures for each Tcyc. The PDFs were created from
these plots on the breathing traces, and are referred to as the residual beam delivery
positions. Figure 5-4 shows a PDF of the residual beam delivery positions for the gated
delivery obtained from figure 5-3; however, each PDF was not normalized and showed
the number of plots for each residual beam delivery position. The PDF of the breathing
trace under the gate threshold level was also shown as a reference. This was used as
the PDF of the continuous direct current beam delivery assuming the respiratory gated
cyclotron beam delivery. The horizontal axis in figure 5-4 corresponds to the
amplitude information of the breathing trace. The bin size of the PDF was 0.01 cm.
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The vertical axis expressed the number of plots for each bin of PDF corresponding to
the residual beam delivery position for each a fixed Tcyc of 2.7~ 6 s, patient breathing
cycle specific Tcyc and the variable Tcyc. The left edge of figure 5-4 was regarded as the
threshold level and the right side of the graph corresponds to the expiration phase of
breathing data. Figure 5-5 shows the cumulative PDF calculated from figure 5-4. The
vertical axis was normalized by the total number of plots for each Tcyc and the
breathing trace under the gate threshold level in order to easily recognize the point of
R95. R95s obtained from the CDF graph were analyzed with each gate threshold level
for all breathing traces.
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Figure 5- 3. Example of the simulation result of 100 MU equivalent beam delivery
at a gate threshold for a 30% duty cycle for each synchrotron operation cycle,
Tcyc,. Each rectangular box shows breathing trace under the gate threshold level (gray
line), synchrotron magnet excitation pattern (green line) with Tcyc and spill delivery
(different color) and the spill delivery points projected on the breathing trace
(expressed with symbols). In the simulation, each spill delivery event was recorded and
plotted on the breathing trace. The patient specific Tcyc used for this simulation was
Tcyc=4.9 s.
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Figure 5- 4. Probability density function (PDF) of the beam delivery points
plotted on the breathing trace in figure 5-3 for each Tcyc. The horizontal axis
corresponds to the amplitude information of the breathing trace (cm). The vertical axis
represents the number of symbols for each bin. The gate threshold corresponds to the
vertical axis (blue line) on the graph. The PDF shows the number of beam delivery
positions (amplitude) on the breathing trace (not normalized) for seven different types
of Tcyc. The symbols for each PDF correspond to the symbols with same colors in
figure 5-3.
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Figure 5- 5. Cumulative distributions of the beam delivery points plotted on the
breathing trace in figure 5-3 for each Tcyc. This is computed from the PDF in figure
5-4 by cumulative addition from the left side (gate threshold) on figure 5-3. The
horizontal axis is the same as the PDF (cm). The R95 value represents the relative
distance from the amplitude value at the gate threshold to the point indicated by arrows
that shows 95% of the total number of beam delivery points (cm).
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5.3.1 Effect of the starting phase of beam delivery
Figure 5-6 shows the histograms of the standard deviations (SD) of R95 for each
simulation with the gate threshold level offset for duty cycles of 10%, 20% and 30%
and Tcycs accounting for the starting phase from 0~2π using the total breathing traces
(n=70). The SD for one breathing trace (patient) was calculated from the R95 values
obtained by repeating the simulation from 0~2π for each patient breathing trace. It was
repeated for each Tcyc.
For Tcycs of 2.7 s and 3.0 s, a group of shorter Tcycs, figure 5-6 showed that
there was almost no change seen in the distributions of the standard deviations of R95
and the peak positions were consistent at 0.01 regardless of the gate threshold level.
For Tcycs of 5.0 s and 6.0 s, a group of longer Tcycs, and also for the patient-specific
Tcyc pattern (Tpbre), the standard deviations of R95 for the gate threshold level offset at
the 30% duty cycle (DC) were distributed more widely than the distributions for the
10% and 20% DC. However, the distributions were gradually skewed toward 0 with a
decrease in the gate threshold level. On the other hand, the standard deviations of R95
for the variable Tcyc were quite different from the results of both the shorter and longer
Tcyc groups. The SDs of R95 were <0.01 and had the smallest deviation for most of the
breathing traces. The distribution did not change and its peak position was consistent
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within a SD of less than 0.01 regardless of the gate threshold level. This result showed
that there was almost no impact of the starting phase effect on the beam delivery point
in the variable Tcyc operation regardless of the gate threshold level. Thus the variable
Tcyc enables one to provide highly reproducible proton beam delivery with respiratory
gating. The reproducibility was not influenced by patient breathing pattern, gate
threshold level or the starting phase of beam delivery.
For other Tcyc operations, the starting phase of beam delivery caused
0.01~0.02 standard deviations of R95 for the 30% DC and it also varied depending on
breathing pattern. This peak area gradually was shifted toward 0.01 or less as the gate
threshold changed dropped from a 30% DC to a 10% DC. In spite of this change, the
minimum inherent resolution of the amplitude information of RPM was approximately
0.01~ 0.02. Therefore, 0.01~ 0.02 of the standard deviations of R95 caused by the
starting phase was smaller than the uncertainty of the amplitude information of the
RPM data itself. Thus, the simulation results have demonstrated that the starting phase
effect can be regarded as almost negligible. Therefore, the starting phase of beam
delivery was ignored in subsequent simulations, and just the average values among
five R95s obtained from each simulation accounting for the starting phase effect were
used as to represent for each simulation result.
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Figure 5- 6. Histograms of the standard deviations of R95 accounting for the
starting phase of beam delivery in each simulation. The horizontal axis represents
the standard deviations of the R95 value with several synchrotron operation cycles, Tcyc.
Each value of the standard deviation of R95 expresses how each simulation (with Tcycs
for each gate threshold level based on one breathing trace) was influenced by the
starting phase effect. Each graph shows how this would change for breathing pattern
(70 breathing traces) and the gate threshold level from a 30% DC, 20% DC, and 10%
DC.
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5.3.2 Effect of synchrotron operation with Tcyc
Figure 5-7 shows the summary of the R95 distributions resulting from the simulations
performed with 70 breathing traces for each combination of synchrotron operation
cycles (Tcyc) and three gate threshold levels with duty cycles of 10%, 20% and 30%.
Similarly the R95 distributions for the breathing trace under each gate threshold level
were also shown in figure 5-7 and named “reference”. This may be also useful to
compare simulation results of synchrotron-based respiratory gated delivery with
various types of Tcyc with an ideal respiratory gated beam delivery using a continuous
beam such as cyclotron-based beam delivery. In this case the PDF of the beam delivery
is almost identical to the PDF of each breathing trace under a given gate threshold
level.
The R95 distributions in figure 5-7 show that the R95 distributions of the longer
Tcyc group (>4.0 s) were almost same for each gate threshold level. Here, most of the
spills were delivered consistently within a certain residual position based on each
breathing trace. It is from each gate threshold level to R95= 0.1 cm at the peak of each
R95 distribution for all gate threshold levels of 30%, 20%, and 10% duty cycles. On the
other hand, for the shorter Tcyc (Tcyc=2.0 s and Tcyc=3.0 s), all R95 distributions seemed
to be gradually shifted toward the expiration phase (on the right side of each graph).

115

For the R95 distribution with a gate threshold level of a 30% duty cycle, the mean
values of the R95 distribution (0.32 cm for Tcyc=2.7 s and 0.30 cm for Tcyc=3.0 s by an
expression of amplitude information in the breathing trace) were shifted by
approximately 0.05 - 0.07 cm toward the expiration phase compared to the R95
distribution for a longer Tcyc (mean value was 0.25 cm). This means that most of the
spills were delivered within 0.3 - 0.32 cm by the breathing trace expression from the
gate threshold level for a 30% duty cycle. It is wider than the result further longer Tcyc,
which also indicates that the residual position uncertainty expressed by the breathing
trace increases for the shorter Tcyc operation. In other words, the reproducibility of the
residual position, again expressed by breathing trace, during the spill delivery starts to
become inconsistent when using the shorter Tcyc, and also becomes more inconsistent
when using a higher gate threshold level. Furthermore, when comparing the results
from the shorter Tcyc with the results of the reference (all data points of the breathing
trace under the gate threshold) in figure 5-7, all R95 distributions for the shorter Tcyc
(Tcyc<4 s) were similar to the distribution of the reference for all gate threshold levels.
This shows that the residual positions expressed by the breathing trace during the beam
delivery with the shorter Tcyc were similar to those with a continuous beam delivery (or
cyclotron-based respiratory gated beam delivery). On the other hand, for the case of

116

longer Tcyc (Tcyc>4.0 s), the residual position expressed by the breathing trace during
beam delivery was different from the one with continuous beam delivery.
For the case of patient specific Tcyc set to approximately the average breathing
cycle (Tbre) for each patient, the R95 distribution was quite similar to the one for longer
Tcyc, and the difference in the mean values of the R95 distribution was less than 0.02,
(figure 5-7). Therefore, the use of a patient specific Tcyc pattern did not provide a
remarkable benefit. With respect to variable Tcyc operation, there was a unique result in
the R95 distribution. The change in the mean values of the R95 distributions for different
gate threshold levels was 0.21 cm for a 30% duty cycle to 0.14 cm for a 10% duty
cycle. This was a smaller change than for any other Tcyc operation as well as a change
in standard deviations which associated with the breathing pattern. Hence, the variable
Tcyc mode of operation provided robustness to respiratory gated beam delivery
regardless of gate threshold level and/or patient breathing pattern. This means that, as
explained by the R95 distributions, the quality of beam delivery was reproducible with
a small residual position. In addition, one could state that the variable Tcyc provided a
more “precise” beam delivery to the target than the other Tcyc patterns.
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Figure 5- 7. Histograms of R95 for each Tcyc and DC as the gating threshold level
for 70 breathing traces. The mean value and standard deviation (SD) for each
distribution are shown in the graphs.
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5.3.3 Effect of the respiratory gate threshold level
In figure 5-7, for the gate threshold of a 30% duty cycle, the R95 distributions were
skewed toward the threshold side (at R95=0) as Tcyc become longer, as well as for the
patient specific Tcyc and the variable Tcyc. As a general trend for all R95 distributions
with a gate threshold level for the 30% duty cycle, the peaks of R95 distributions were
located around 0.1~ 0.2 cm and average value of the R95 distribution for all Tcyc was
0.29±0.04 cm. The variances of the R95 distributions for each Tcyc operation increased
up to 0.15 in the root mean square (RMS). Similarly the averages and variances of the
R95 distributions for gate threshold levels of the 20% and 10% duty cycles are listed in
table 5.1. It should be noted that if one uses a higher gate threshold level, the R95
distribution is more sensitive to the synchrotron operation cycle of Tcyc. However, for
the gate threshold level of a 10% and 20% duty cycle, there was not as big change in
the R95 distribution (0.16±0.02, 0.2±0.03 in average and 0.09~ 0.12 in RMS) and it
became less sensitive to the synchrotron operational parameter, Tcyc compared with the
gate threshold of a 30% duty cycle. Table 5-1 supported that, as already seen in figure
5-7, the R95 distributions became skewed with decrement in the gate threshold level.
The skewness of the R95 distribution for the gate threshold level of a 10% duty cycle
was similar to the one for the 20% duty cycle in the shorter Tcyc operation. This trend
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became more consistent for longer values of Tcyc (Tcyc>3.0 sec). From these results it is
clear that selection of a gate threshold level is an important factor to offer precise beam
delivery in respiratory gating. In order to achieve it, the gate threshold level should be
selected to be neither too high nor too low, and an optimal gate threshold has a robust
quality with regard to precision of the beam delivery independent of both the Tcyc and
patient breathing. Therefore, notable findings in this study were that, first for a longer
Tcyc(Tcyc≥5.0), the R95 distribution has robustness and precise beam delivery is
available regardless of the gate threshold setting (figure 5-7). Secondly the variable
Tcyc was the most robust synchrotron operation pattern for respiratory gating and was
not affected by gate threshold level or patient breathing because for the variable Tcyc
operation, the R95 distributions ranged 0.14±0.07, 0.17±0.09 and 0.21±0.12 in for the
gate threshold level of the 10, 20 and 30% duty cycles respectively. These were the
minimum values compared with other R95 distributions of Tcyc for each gate threshold
level.
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Table 5- 1. Summary of the mean and standard deviation (SD) values in the overall
R95 distributions with Tcyc for each gate threshold level used in figure 5-7. RMS stands
for root mean square.
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5.4 Discussion
The results discussed above show that, for respiratory gated passively scattered proton
beam delivery, the precision of the beam delivery depends on the combination of the
magnetic excitation cycle of the synchrotron operation (Tcyc) and the gate threshold
level chosen. Secondly the impact of the starting phase effect on the precision of the
proton beam delivery was almost negligible. It should be noted that even if the proton
beam delivery with respiratory gating starts at any phase, the consequential precision
does not change.

Figure 5-7 showed when the gated beam delivery is most probably

undergone on the basis of breathing information. By looking at the term R95, one can
see that most of gated beam delivery occurs when the amplitude of the breathing trace
is in between the gate threshold level and R95.
In this section, the focus was placed on the breathing data points between each
gate threshold level and R95. The ratio of these data points to the total breathing data
for each patient breathing trace was defined as the effective duty cycle (DC). This was
compared with the duty cycle originally defined and used as the gate threshold level,
which is defined as the nominal duty cycle. The ratios of the effective duty cycle to the
nominal duty cycle are averaged over the all breathing traces used in this study and
plotted in figure 5- 8 with respect to synchrotron operation with Tcyc and gate threshold
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level. The maximum and minimum values of each distribution of the effective duty
cycle for each Tcyc were also shown in graph for each threshold level. As the plots of
the “reference” in figure 5-8 show, the closer the ratios of the effective duty cycle to
the nominal duty cycle were to 0.95, the more uniform was the total beam delivery
over all spills to the residual motion expressed by the breathing traces. However, when
the ratios of the effective duty cycle to the nominal duty cycle were less than 0.95, the
beam delivery was non-uniform and occurred at the residual positions between the gate
threshold level and R95. For the former case, although each spill delivery is basically a
uniform random delivery and represents statistically more uniform beam delivery over
all spills. For the latter, the residual positions during beam delivery cluster toward the
gate threshold following a Poisson distribution. For the case of the variable Tcyc, the
residual position error in accordance with R95 was smaller compared with any other
Tcyc, and the ratios of the effective duty cycle to the nominal duty cycle, were 0.71,
0.78 and 0.83 for the gate threshold levels of the 30%, 20% and 10 % duty cycles,
respectively. These numbers were smaller than those with any other Tcyc for each
condition. Therefore respiratory gated beam delivery with variable Tcyc operation has
less uncertainty. This indicates that the beam delivery with the variable Tcyc has the
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best reproducibility and can occur at a more consistent phase expressed by a smaller
residual uncertainty than any other case of Tcyc.
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Figure 5- 8. Ratio of effective duty cycle to nominal duty cycle averaged over 70
breathing traces. The width between the maximum and minimum values represents
how the beam delivery is independent of a patient breathing pattern. The effective duty
cycle of the “Reference” (all data points of the breathing trace under gate threshold
level) is the ideal uniform beam delivery and should be about 95 because R95 is the
value indicating the points of 95% of the cumulative residual positions. The maximum
and minimum values of the Reference are, in this case, related to inherent uncertainties
caused by a limitation in the number of data points of breathing trace.

125

As consideration is taken into the beam quality with respect to the consistency or
reproducibility point of view, there is enough information in figure 5-8 to discuss the
quality of the respiratory gated proton beam delivery. The effective duty cycle was
utilized to express that most (95%) beam delivery occurred when the patient breathing
trace was within the area between the gate threshold level and R95. On the other hand,
another area including the remaining 5% was conversely interpreted to be where most
beams would not likely be delivered. The focus is placed on this area. The duty cycle
calculated by the breathing signal data points under the R95 level was defined as a
non-beam delivery duty cycle (nDC). This means that when the breathing trace is
under the level of nDC, beam delivery scarcely occurs. The nDCs calculated for 70
breathing traces for each value of Tcyc and gate threshold level are listed in Table 5-2.
The numbers in the table show, as nDC becomes greater, the area that the spills would
not be delivered becomes larger compared with the effective duty cycle. This reveals
that the probability that the spills would be uniformly delivered within the duty cycle
becomes lower. A decrease in the probability of the beam delivery is in general
observed in the end-expiration phase except in the case that the breathing pattern drifts
up and down. For example, for the shorter Tcyc based synchrotron operation (Tcyc=2.7
and 3.0s), the average values of the nDC for each gate threshold condition were less
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than 10%. The probability that the spills were not delivered was quite low and
therefore the spills were almost uniformly delivered and the likelihood of
simultaneously missing the beam delivery in end-expiration phase is less over all spills
when the breathing signal was below the gate threshold level. In table 5-2, the
variances of nDC (mean, maximum and minimum values of nDC for all breathing
traces) show how much the variability of the missing beam delivery event were
influenced by patient breathing traces, Tcyc and gate threshold level. For a longer Tcyc
operating mode (Tcyc= 5 s and 6 s) or variable Tcyc mode, the average nDCs were
higher compared with the shorter Tcycs. The probability that the spills were not
delivered was three to four times greater for the gate threshold level of a 30% and 20%
duty cycle, and two and three times greater for gate threshold of a 10% duty cycle as
compared to the shorter Tcyc operation modes. The probability became much higher
with use of a higher gate threshold. It should be noted, however, that the longer Tcyc
and variable Tcyc operations alternatively have at least one benefit that the synchrotron
operation with larger nDC offers more reproducible beam delivery even for an
irregular breathing pattern. Figure 5-3 shows several colored symbols superimposed on
the breathing trace for each Tcyc operation to express the spill delivery point resulting
from simulation. For the results of the shorter Tcyc, each spill delivery is widely
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distributed, and the residual positions where the beam delivery occurs and its R95 were
easily influenced by an irregular breathing pattern especially when the patient’s
baseline drifted up and down. However, for the longer Tcyc and the variable Tcyc, the
spill delivery points expressed by colored symbols in figure 5-3 were relatively
distributed close to the gate threshold level and barely affected by such an irregular
breathing pattern. Thus, the benefit of the longer Tcyc and variable Tcyc operations was
a robust reproducibility for the beam delivery independent of patient breathing pattern.
The reproducibility should be regarded as one criterion to indicate the quality of
respiratory gated beam delivery. However since relating the accuracy of the beam
delivery directly to residuals has not been investigated in this study, the term of quality
discussed in this study was limited to precision only. A more comprehensive
discussion of the quality of the beam delivery integrating both accuracy and precision
needs to be done as a next step.
For both the respiratory gated beam delivery mode and free-breathing based
beam delivery mode, the current proton treatment planning system needs to account for
the target motion uncertainty using multiple phases of CT data sets, an average CT
made from a four-dimensional CT and/or a free-breathing CT (Engelsman 2006, Kang
2007 and Mori 2010). Especially for the synchrotron-based respiratory gated mode,
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one should account for not only the dosimetric impact of target motion uncertainty but
also the most likely target position in which most of the spills would be delivered
based on the results obtained in this study. As some of the results in this study already
showed, it is not guaranteed that all spills would be delivered uniformly to the residual
motion under the gate threshold level, which depends on synchrotron operation. For
example, when using the shorter Tcyc for respiratory gating, it is preferable to use a CT
data set averaged over some series of CT data sets in the expiration phase (under the
gate threshold level) for treatment planning rather than a series of expiration phase CT
data because most of the spills are delivered uniformly to the residual motion under the
gate threshold. On the other hand, for the variable Tcyc or longer Tcyc operations, since
the probability of missing the spills delivered in the end-expiration phase is higher,
treatment planning with either a series of end-expiration phase CT data sets or the
averaged CT data set mentioned above would not be enough to account for this effect.
Therefore, for the variable Tcyc or longer Tcyc synchrotron operations, it is suggested
that weighting factors based on R95 should be applied to the averaged CT data set used
in the dose calculation for treatment planning. Furthermore, since the breathing traces,
are usually acquired from external patient breathing motion, they do not always
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express accurate residual motions (Kini 2003, Tsunashima 2004). Therefore, the
uncertainty in the breathing traces should be taken into account in treatment planning.
It should be noted that these results and discussion are based on the
synchrotron at PTCH, and results may be slightly different for each synchrotron
manufacturer or facility because the spill shape and length in the time domain and
other parameters associated with synchrotron operation specified by each facility are
different. According to the specifications of the synchrotron used in this study, as
shown in figure 5-1, each spill is controlled to have a stable output that is consistent
spill by spill. However, some other facilities use a spill that appears skewed toward the
beginning of the spill such as a Poisson distribution (Noda et al 1996). In this case,
most of the spills are delivered in the beginning of the beam extraction phase.
Assuming respiratory gated beam delivery was used with this spill structure, the
overall effective duty cycles would be much narrower than for the variable Tcyc and
longer Tcyc operation, and eventually actual residual motion during beam delivery
would be much smaller and the most of spills would rarely be delivered in the
end-expiration phase.
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Table 5- 2. Non-beam delivery duty cycle. The numbers are duty cycles for which
beams are probably NOT delivered for each gate threshold level. The distribution of
the non-beam delivery duty cycle for all breathing traces are shown with average,
maximum and minimum values for each Tcyc and gate threshold level. Large values
suggest that the probability of missing beam delivery in end-expiration increases and
most of beam is delivered near the gate threshold level (Tsunashima et al 2010).

131

5.5 Conclusions
As a feasibility study of the implementation of synchrotron-based respiratory gated
beam delivery, this investigation was focused on the quality of beam delivery. The
simulation of realistic respiratory gated beam delivery was performed using patient
breathing data and the magnet excitation pattern of a synchrotron.. The results obtained
from this study provided some useful information for choosing an appropriate
synchrotron operation pattern, Tcyc, in order to perform more precise beam delivery
with respiratory gating. The reproducibility of beam delivery was used as criteria to
assess the quality of respiratory gated beam delivery. The overall results obtained from
this study and the results from the chapter 3 offer the optimal parameters for high
quality and highly efficient beam delivery for respiratory gated passively scattered
proton therapy. From these results, one can conclude that the variable Tcyc operation
can offer the most efficient and precise beam delivery for synchrotron-based
respiratory gated proton beam delivery in passively scattered mode.
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Chapter 6. Specific aim 2: Beam scanning delivery Part I
Assess the accuracy of dose delivery in respiratory gated proton therapy with
scanning beam delivery: Experimental evaluation of the interplay effect for
proton scanning beam delivery

6.1 Introduction
Scanning beam delivery cannot only provide a uniform dose distribution to the target
but also spare the dose in organs at risk (OAR). It makes it possible to create a
complicated dose distribution. Therefore head and neck tumors could be more suitably
treated with the proton scanning beam technique. Pediatric cases where a small field
and much more limited dose need to be delivered could significantly benefit from
proton scanning beam treatment. Furthermore, the higher dose uniformity limited only
to the target would be naturally desired in lung or liver treatments as well. However,
because the dose distribution is composed of a superposition of many beamlets (spot
beams) in scanning beam delivery, the dose distribution is very sensitive to the errors
in the reproducibility of the position of the target and its surrounding organs.
Particularly for the lung and liver, where organs move with a periodic motion mainly
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due to the breathing, the quality of the delivered dose is a main concern for scanning
beam delivery to the moving target. This is challenging, and the use of the respiratory
gating technique could be a more helpful approach to achieve it.
The main goal in this chapter is to evaluate the feasibility of respiratory gated
scanning beam delivery. It is also very important to comprehend the impact of motion
on the dose distributions in scanning beam mode. Several studies concerning the
interplay between motion and scanning beam delivery have been published; however,
these are based on simulation studies (Kraus 2011, Knopf 2011) and no real measured
data has been published for proton scanning beams. However, some experimental
studies of the interplay effects for carbon beams have been published (Bert 2008,
Furukawa 2011). Unfortunately, for a clinical case with the target volume in a
heterogeneous medium, it is very complicated to analyze the interplay effect arising
from the 3D dose deterioration caused by mixing many scanning beams with different
energies in the depth direction.
Therefore, in this study, a more streamlined experiment was carried out to
investigate the interplay effect for proton scanning beams. The aim of this experiment
is to understand how scanning beam delivery and its associated dose distributions
would be affected by motion in a very simple situation. The experimental study
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focuses on a fundamental understanding of the interplay effect by mono energy scan
beam delivery in a uniform water equivalent material. The measurements performed in
this study are basically two dimensional measurements using uniform beam scanning
for a single energy layer. The deteriorations in the dose distribution caused by the
motion for one energy layer were analyzed by the comparison of the dose distribution
without motion.
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6.2 Materials and Methods
For the measurements, 2D lateral dose distributions at a certain depth were acquired
using a 2D chamber array detector. The motion effect was measured using a moving
plat platform and the 2D detector. Details of the equipment and the measurement
procedure of the measurement are discussed below.

6.2.1 Equipment
6.2.1.1 2D array detector
The I’mRT matrix (IBA, Schwarzenbruck, Germany figure 6-1) was used for 2D dose
measurements. The matrix is composed of chamber arrays with 4.5 φ x 5mm height
chambers placed in a 32x32 array with 7.62 mm spacing (center to center) between
each chamber. Although the chamber array does not have as fine resolution as films,
the benefit is that first it is very easy to perform repeat measurements, and secondly it
offers a real time direct reading though a PC. Thus there is no need for
post-measurement processing, whereas for film measurement there would be a need for
developing and/or digitizing the irradiated films and for careful preservation of them as
well. Also, the linear energy transfer (LET) effect is nearly negligible for chamber
measurements compared with film measurements. It is very convenient for proton
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beam measurements because the proton volume dose distribution is composed of many
different energy proton beams, and if using films, the LET effect differs for each beam
energy and needs to be corrected for accurate results. Therefore, the 2D array detector
is the most suitable detector for this type of measurement. Regarding the resolution
issue, since the acquired 2D dose can be interpolated, 4 mm resolution is used in the
measurement, and the irradiated field was a very simple square field, it is not a relevant
problem in this measurement.
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Figure 6- 1. ImRT MatriXX (IBAⓇ, Schwarzenbruck).
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6.2.1.2 Moving plat form and motion
The moving plat form is composed of an acrylic board combined with sliding rails, a
stepping motor unit (VXM stepping motor controller, VELMEX, Inc.) and a PC
(figure 6-2). The stepping motor is attached to a lead screw with a drive nut. As the
stepping motor is controlled to rotate the axis, the lead rotation is also synchronized
with the motor and consequently the drive nut goes back and forth on the lead screw.
Since the motion platform is directly connected to the drive nut, the drive nut motion
reflects on the platform motion. Since only one stepping motor is used in this unit, the
motion of the platform expresses one axis (dimensional) motion, linear motion. The
motion pattern is programmed beforehand and the motion data were sent to the
stepping motor control unit through the PC.
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Figure 6- 2. Setup for the measurement (upper) and a sinusoidal motion pattern
(lower).
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The platform motion followed a theoretical patient breathing model. The use of the
sinusoidal motion is one of the well known breathing models (Lujan 1999):

f(t)=A*cosn(π/T*t+ψ)

A: Motion amplitude [mm]
T: Cycle period [s]
Ψ: Original phase

In this study, a sinusoidal function raised to the 4th power motion (n=4) was used. The
phantom moved back and forth in the superior-inferior (SI) direction. The maximum
superior amplitude of zero was set at isocenter and the moving platform moved down
to the minimum amplitude of –A with period T. Several different motion patterns with
the combination of the cycle T= 3 and 5s and the amplitude A= 2, 5, 10 and 20 mm
were used to observe the dosimetric impact due to motion.
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6.2.1.3 Scan beam field and its delivery pattern
Measurements were performed for a simple geometry with uniform water equivalent
materials using a mono energy beam. The energy of proton beam was 173.7 MeV,
whose residual range is equivalent to 20 cm in water. The energy was chosen based on
the assumption that the maximum energy most often used in thoracic treatment is
approximately 20 cm in water. The spot size with this energy was approximately 19.6
mm (FWHM) at the Bragg peak in water (figure 6-3). Figure 6-4 shows the
relationship between the proton energy and the spot size at the Bragg peak. As seen in
figure 6-4, the spot size around the energy area used in this study expresses
approximately the minimum spot size. Thus, this experiment was performed with the
minimum spot size available in our facility (Gillin 2010).
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Figure 6- 3. Spot size of the 173.9 MeV beam at the Bragg Peak.
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Figure 6- 4. Relationship between energy and spot size calculation in air, measured
water (Anand 2010) and measured in ABS.
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Using the spot beam, a 10x10 cm2 field was created with inter-spot spacing of 8 mm
along both the vertical (IS direction) and horizontal axes (Zhu 2010). In order to make
the 10x10 cm2 field, 13 spots were delivered in both the horizontal and vertical
directions, resulting in 13x13=169 spots in total. Regarding the spot delivery pattern,
the sequence of the spot scan delivery at our facility is governed by spot position (x
and y), spot weight and beam energy (scanning layer). The user can arrange the spot
delivery sequence to suit one’s needs. Therefore, in this series of measurements two
types of spot beam delivery patterns were prepared: scan pattern one consists of spot
delivery starting from the edge of the field, and moving to each successive spot
position by 8 mm in the direction of phantom motion (the Y direction) until all 13
spots are delivered and then moves perpendicular to the phantom motion (the X
direction), by 8 mm, and then 13 spots are delivered in the opposite direction (figure
6-5 a). Scan pattern two is perpendicular to the scan pattern one, and the main beam
scan line is perpendicular to the phantom motion (figure 6-5 b).
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Figure 6- 5. Definition of the coordinate system in a patient and the spot scanning
plane.
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6.2.1.4 Re-painting
The spot beam in PTCH has a deliverable dose limit set from 0.005 MU up to 0.04
MU. The dose range is consistent for all energies. For this reason, it is necessary to
consider the repainting procedure with respect to the deliverable spot dose limitation in
PTCH. Repainting due to the spot dose limit is quite different from the repainting issue
well known as a technique for compensating errors of spot delivery. For example, if
100 MU needs to be delivered to a given volume, in principal a maximum of 25 times
the spot delivery or 25 times paintings are required at the distal energy layer of the
volume.
In the measurements, the 10x10 cm2 field made by 169 spots with 8 mm spot
spacing was defined as a single painting and also used as a reference 2D dose
distribution. For the repainting the spot delivery position started from the last spot
position finished in the previous painting, 169 th spot in the previous scan. The spot
position returns to original spot position by odd times of number of paintings in the
scan delivery pattern used in the measurements.
In order to investigate the relationship between the repainting and the
interplay effect, the beam delivery time or scan speed is also an important parameter.
One spot delivery is composed of two processes; one is spot delivery and the other is

147

the transition to the next spot position. The spot delivery time varies from 1ms for
0.005 MU delivery to 4 ms for 0.04 MU delivery as previously explained in chapter 4.
The spot position transition time also varies depending on the energy and the distance
between the spots. The 8 mm spot spacing used in the measurement takes
approximately 3 ms in both the X and Y directions and it is nearly consistent in these
measurements. Delivery of a single spot beam consequently takes approximately 7 ms
for a 0.04 MU spot dose and 4 ms for a 0.005 MU spot dose.
This study focused on the interplay effect for 0.04 MU spot beam delivery.
The reason for this selection is first because the maximum spot dose is expected to be
delivered especially at the distal end of the proton range, and secondly the total beam
delivery time for 0.004 spot dose delivery is expected to be longest and which could
represent the worst case scenario of the dose deterioration caused by motion. Therefore
the total beam delivery time for creating a 10x10 cm2 field with 169 spots is
approximately 1.18 s for single layer painting. This was repeated from one layer paint
up to 16 paintings, and the change in the dose deterioration by the number of the
paintings was analyzed.
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6.2.2 Setup for the measurements
Figure 6-6 shows the setup for the measurement setting. The experiment was carried
out in the gantry 3 treatment room at PTCH. The gantry angle was 0 degrees. The
moving platform with the stepping motor unit was placed on the treatment couch and
was positioned in order that the origin of the moving platform was set at the isocenter.
The motion was confined to superior-inferior (SI direction) direction on the couch. The
coordinate system on the treatment couch was defined such that the superior direction
was +y and inferior direction was –y, and ±x were similarly defined in figure 6-6. The
2D ion chamber array detector was placed on the moving platform. The center of the
chamber array was set at the isocenter in y= 0 position of the moving platform. Based
on y=0 position, the moving platform unit moved toward the inferior direction, y<0,
down to the motion amplitude of A, y=-A. Therefore, as it was translated into the
patient breathing motion and coordinate system, the platform position at y=0 was the
end-expiration phase and y=-A was the peak of the inspiration phase. The spot position
coordinate system, X and Y corresponded to -y and -x for each. For the detector setup
in the depth direction, the effective center of the chamber arrays in the beam direction,
depth direction, which was 4 mm from the surface of the chamber array detector, was
set at isocenter. Solid water slabs with 19 cm water equivalent thickness were stacked
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on top of the 2D chamber array detector. The unit composed of the water slabs, 2D
chamber array and the moving platform was controlled to undergo sinusoidal motion.
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Figure 6- 6. Setup for the measurement. The moving plat form with controller and
I’mRT MatriXX (2D chamber array detector) were placed on the treatment couch. The
water equivalent blocks were stuck in 19 cm (physical thickness). The gantry angle is
set at 0 degree.
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6.2.3 Measurements
The 10x10cm2 uniform field was delivered to the 2D ion chamber array detector using
a 173.7 MeV beam with an approximately 20 mm spot size (FWHM in water) and 8
mm spot spacing. The two types of scan pattern directions were used to create the field
using scanning directions orthogonal and perpendicular scan to the phantom motion.
The 10x10 cm2 field was delivered for different motion amplitudes: A=0 (reference), 3,
5, 10 and 20 mm and motion cycles T=3 s and 5 s. The same measurements were
repeated changing the number of paintings from 1 to 16 times.

6.2.4 Starting phase effect
As mentioned above, a single painting with 169 spots takes only about 1.2 s. The dose
distributions made during this short time span are therefore very sensitive to object
motion during beam delivery (figure 6-7). Especially since the platform motion used in
this measurement was not a simple sinusoidal motion but weighted on the end
expiation phase, the consequent dose distribution should vary depending on the phase
of motion in which the beam delivery is initiated. This was defined as the starting
phase effect. This does not only affect the dosimetric quality but also the total beam
delivery time for synchrotron-based respiratory gated proton beam irradiation.
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Therefore the measurements under each condition mentioned above were furthermore
repeated at different phases of platform motion. However, since it was difficult to start
beam the delivery at exactly the same phase due to mechanical delay, the beam
delivery was ultimately initiated at two different phases: when the moving platform
was located at the top in the SI direction, phase “+”, and when the moving platform
was at the bottom position, phase “–“ (figure 6-7). Beam delivery with same conditions
was initiated around each phase multiple times, from which the worse and best dose
deterioration were selected as representative results of dose distributions at each
starting phase.
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Figure 6- 7. Example of the starting phase effect.
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6.2.5 Analysis
The dose distributions obtained from measurement, including the motion for each
amplitude and cycle, were compared with the reference dose distribution, which was
the same beam delivery without motion. The comparison focused on the dose
uniformity inside of a certain reason of interest (ROI) because the dose deterioration
caused by the object motion directly reflects on the decrease in the dose homogeneity
relative to the reference uniformity in the ROI. A similar comparison using the
quantified homogeneity was performed to study the interplay effect for a carbon
scanning beam by Bert et al (Bert 2008). Here the dose homogeneity, H, is defined by

H=1-σ/Dave
σ:standard deviation
Dave: mean dose

First, based on the reference dose distribution (no motion), 95%, 90% and 50% isodose
comparisons were delineated as ROI95, ROI90 and ROI50, and the dose homogeneities
of the reference were computed for each ROI and defined as Href, 95, Href, 90 and Href, 50.
Secondly, with the other measured dose distribution including motion, the dose
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homogeneities for each measurement condition (motion cycle, amplitude and the
number of paintings) were also computed inside of the ROIs copied from the ones
made based on the reference dose distributions. These were defined as H95, H90 and H50 ,
where the term “n” indicates the number of paintings (figure 6-8). Concerning the
ratio of H to Href for each isodose comparison, the closer H/Href is to unity, the more
similar is the dose homogeneity with and without motion. The dosimetric impact due
to motion could be seen in the change in the homogeneity ratio, H/Href, with increase in
the number of the paintings for different motion amplitudes and cycles. The impact due
to the difference in the scan direction, orthogonal and perpendicular to the object
motion, was also investigated.
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Figure 6- 8. Homogeneity calculation for the 95%, 90% and 50% isodose lines
made on the reference (no motion) dose.
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6.3 Results
6.3.1 Parallel scan direction
Figure 6-9 shows the 2D dose distributions acquired under each condition with the
motion cycle = 3 s for various motion amplitudes and the number of paintings. 2D dose
distributions for two different starting phases were shown for each condition. The right
side of the figure shows the 2D dose distribution with 3 mm motion, extending to 5
mm, 10 mm and 20 mm motion. It is seen that the dose distribution is deformed with
increment in the motion amplitude (right to left). The top row in figure 6-9 shows the
measured data for a single painting, 169 spot delivery. For 3 mm motion, it appears
that the dose distribution is nearly the same as the reference dose (no motion). For 5
mm motion (figure 6-10), there was some deformation seen on the peripheral area, and
this became more apparent in the dose distribution for 10 mm motion. For 20 mm
motion, not only peripheral dose deformation but also a hot spot (white spot in the
figure) in the center of the dose distribution was observed. As the number of paintings
was increased from the top to the bottom in figure 6-9 and 6-10, the dose deformations
seen in the top of row on each figure were somehow blurred by repeating the spot
delivery multiple times. The results for T=5 s motion were in total slightly better than
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for T=3 s for each condition because slower platform motion showed less impact
against the scan pattern.
Figure 6-11 shows the homogeneity ratio for each of the measured conditions
and how the homogeneity ratios were quantitatively improved by the number of
paintings for each phantom motion amplitude and breathing cycle. The worst and best
values of homogeneity ratio caused by accounting for different starting phases were
expressed for each condition on the graphs. The homogeneity ratios were compared for
each 95, 90 and 50% isodose comparison based on the reference dose distributions.
The starting phase effect had a great impact on the dose homogeneity in the single
painting for 20 mm and 10 mm object motion regardless of the motion cycle. However
the starting phase effect was greatly compensated by the repainting. For the T=3 s
motion results, the differences in the homogeneity ratio with single repainting were
11%, 15% and 18% for 95%, 90% and 50% comparison respectively. These
differences reduced to less than 2~3% for all results from two times paintings. For T=5
s and 20 mm motion, the results of the starting phase effect were 13% 18% and 27%
for each isodose comparison, and these were improved down to 10% for all cases. This
result represented the worst result of the starting phase effect. Even in this case, the
differences caused by the starting phase were less than 3% for two times paintings.
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For a single painting, the homogeneity ratio was very sensitive to the motion
amplitude. The homogeneity became worse with increment in the object motion. The
average homogeneities taken between the + and – starting phase were minimum for
each result; however, these were improved by repainting, and as a general trend, the
homogeneities seemed to reach at a certain value from 8 times paintings for all results.
The average homogeneity of 95% isodose comparison were over 0.97 for 20 mm
motion and 0.99 for 10 mm motion for both 3 s and 5 s motion cycles. The 90%
isodose comparison was above 0.95 for a 3 s cycle and 0.96 for a 5 s cycle for 20 mm
motion, and above 0.99 for both 3 and 5 cycles and 10 mm motion. For the 5 mm and 3
mm motion, all results for homogeneity were above 0.98 regardless of number of
paintings, motion amplitude and motion cycle.
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Figure 6- 9. Dose distributions for the parallel scan pattern with 3 s motion and
amplitude of 3~ 20 mm (left to right) and various numbers of paintings (top to
bottom). The phase + is defined as end-expiration phase (the platform position=0) and
the phase – is defined inspiration phase (the plat form position= 3, 5, 10 and 20 mm). ↑
is the phase changing from phase - to phase +. ↓ is the phase changing from phase + to
phase –. H/Href represents the homogeneity ratio of 95% isodose comparison for each
condition.
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Figure 6- 10. Dose distributions for the parallel scan pattern with 5 s motion and
amplitude of 3~ 20 mm (left to right) and various numbers of paintings (top to
bottom).
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Figure 6- 11. Homogeneity ratio for the parallel scan pattern and the improvement
caused by repainting for each motion pattern.
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6.3.2 Orthogonal scan direction
Figure 6-12 and figure 6-13 show the 2D dose distributions for the orthogonal scan
direction for a motion cycle of 3 s and 5 s for each. For the result of 3 mm motion,
similarly there was no motion impact observed. For 5 mm motion, some dose
non-uniformity and hot spots that were higher than the maximum dose on the reference
dose distribution were observed, and the penumbra of the dose distribution in the SI
direction became smeared out in the platform direction. For 10 mm motion, the dose
distribution was skewed toward a certain location. The line-by-line scan pattern
appeared to be synchronized with the object motion for a single painting (169 spot
delivery). When the line by line scan was synchronized exactly with the object motion
moving in the opposite direction, the change in dose distribution for 20 mm motion
was seen as an oblique line inside of the dose distribution. Although the
non-uniformity of the dose distributions for the orthogonal scan direction was quite
different from the parallel scan pattern, the dose non-homogeneity was quite blurred by
repeating the spot delivery multiple times.
Figure 6-14 quantitatively expresses the result of the dose distributions in
figure 6-12. For the dose with 3 mm motion, the homogeneity ratio was above 0.98 for
all isodose comparisons regardless of the number of paintings and degree of motion.
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The homogeneity ratios of the dose distribution with the 5 mm motion were over 0.95
for any measured condition as well. From 10 mm, the differences in the homogeneity
ratio due to the starting phase effect were not improved by repainting. The
homogeneity ratios with orthogonal scanning were so sensitive to the motion that the
homogeneity plots were deviated (scattered). Unlike the results for the parallel scan
pattern, the starting phase effect was almost unavoidable regardless of the number of
paintings. Although the average value of the homogeneity ratio for the result of 10 mm
motion became gradually better by repainting, the homogeneity ratio was over 0.98 for
the 95% and 90% isodose comparisons from 6 times paintings for both 3 s and 5 s
cycle motion. For the result of 20 mm motion, similarly the average homogeneity ratio
reached 0.95 for the 95% and 90% isodose comparisons with 3s cycle motion and 12
times paintings; however it was under 0.95 for 95% and 90% isodose comparisons
with 5 s cycle motion.
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Figure 6- 12. Dose distributions for the orthogonal scan pattern with 3 s motion
and amplitude of 3~20 mm (left to right) and its repainting effect (top to bottom).
The phase + is defined as end-expiration phase (the platform position=0) and the phase
– is defined inspiration phase (the plat form position= 3, 5, 10 and 20 mm). ↑ is the
phase changing from phase - to phase +. ↓ is the phase changing from phase + to phase
–. H/Href represents the homogeneity ratio of 95% isodose comparison for each
condition.
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Figure 6- 13. Dose distributions for the orthogonal scan pattern with 5 s motion
and amplitude of 3~20 mm (left to right) and its repainting effect (top to bottom).

167

Figure 6- 14. Homogeneity ratio using the orthogonal scan pattern for each motion and
the degree of improvement by repainting for each motion pattern.
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6.4 Discussion
The proton beam scan pattern and the impact of the object motion on the scanned dose
distributions were investigated for several conditions including the object motion
patterns, motion amplitude and motion period. Dosimetric comparison between the
parallel and orthogonal scan to the moving object showed that the parallel scan pattern
achieved the better homogeneity, which was also improved by increasing the number
of paintings up to 12 times. The number of paintings also improved the starting phase
effect in the parallel scanning pattern. Figure 6-15 summarizes the dose homogeneity
ratios shown in figures 6-9, 6-10, 6-12 and 6-13. Comparison of the dose homogeneity
between the parallel scan pattern and orthogonal scan pattern were represented for 95%
isodose comparison. Each point was the homogeneity ratio averaged over the starting
effect for each condition, the number of paintings, the motion cycle and amplitude (20
mm and 10 mm only). The solid circle and square represented the homogeneity ratio
for the parallel scan pattern with 3 s and 5 s motion cycles respectively. The open
circle and square were similarly the homogeneity ratio of the orthogonal scan pattern
with 3s and 5s motion cycle. These graphs clearly show that the homogeneity with the
parallel scan pattern was always better than the orthogonal scan pattern. The dose
homogeneity made by the parallel beam pattern was not influenced by the change in
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the motion cycle. The variance of the dose homogeneity reached seemed saturated
around 8 times paintings. The dose homogeneity of the orthogonal painting pattern was
not as good as the parallel scan pattern, and was easily influenced by the object motion
cycle. The difference seen for the orthogonal painting pattern between 3 s motion
(open circle) and 5 s motion (open square) from 1 to 4 times paintings, which was not
seen in the parallel scan results, became considerably minimized around 8 times
paintings. This shows that the orthogonal scan pattern is more sensitive to not only
motion amplitude but also the motion cycle than the parallel scan pattern. This was
also improved somewhat by repainting. However, in this case, the difference could not
be minimized as much as for the parallel scan. This trend was also seen for 10 mm
motion.
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Figure 6- 15. Average dose homogeneity ratio for the 95% isodose comparisons. The
solid circle and square represented the homogeneity ratio for the parallel scan pattern
with 3 s and 5 s motion cycles respectively. The open circle and square were similarly
the homogeneity ratio of the orthogonal scan pattern with 3s and 5s motion cycle.
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Regarding the homogeneity ratio for less than 5 mm motion, as shown in figures 6-9 –
6-14, the homogeneity ratio of with-motion to without-motion (static: reference) was
above 0.98 for all results in the parallel scan pattern and above 0.98 with 3 mm motion
and above 0.95 with 5 mm motion in the orthogonal scan pattern. Based on the spot
beam conditions in our facility, there is almost no difference in the dose homogeneity
with the scan beam delivery to a moving and non-moving object (but the object is
assumed to be composed of homogeneous water equivalent material).
Bert et al reported the dose homogeneities based on a single layer with a raster
scanned carbon beam delivery to a moving phantom (2010). According to the dose
homogeneity results, which were calculated based on a square field, the homogeneity
ratio of each condition to the static homogeneity (no motion) was estimated to be
approximately 80% for 20 mm motion and 93% for 8 mm motion. As compared with
the homogeneity ratio obtained in this study, the homogeneity ratio of the 90% isodose
comparison with 20 mm motion was above 92% for the parallel scan pattern and above
82% even for the orthogonal scan pattern. These values were single painting results,
and the homogeneity ratios became better by repainting as shown in figure 6-15. The
main reason for this difference is the spot size. Our spot beam size was 19.6 mm
FWHM while their study used very narrow 6 mm FWHM. The important point from
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this is that scanning beam delivery with a somewhat larger spot size may be more
motion tolerant. In addition, an appropriate number of the paintings also make the
beam delivery to a moving target more robust.
Knop et al (2011) investigated the treatment planning based interplay effect for
proton spot scanning beam delivery to clinical targets using 4DCT patient data sets.
The spot size used in this study was as half the spot size at PTCH and their
investigation dealt with the interplay effect of volumetric targets. In spite these
differences, the results obtained in this study support their results at least with respect
to the data with the single beam field. The motion amplitude, beam delivery starting
phase, scan direction and the need for repainting were very important factors to
provide uniform dose distributions. Especially for the appropriate number of paintings,
both studies showed that 1~ 4 times paintings did not guarantee improvement in the
dose homogeneity or made it worse; however, for more than 4 times paintings, the
dose homogeneity was successfully improved. Furukawa et al (2010) performed a
study for carbon raster scanning with beam delivery under quite different conditions,
and they also reported that the dose uniformity become close to a certain value in the
standard deviation for 6 times paintings or more.
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It should be noted that the results of the interplay effect obtained in this study were
based on a 2D dose distribution, single layer (plane), using mono energy only, while
Knop et al (2011) investigated the interplay effect with a volumetric target using a
sharper spot beam. If the measurements performed in the present study were to be done
three dimensionally, the results could be somewhat different. to the results could be
similar to those for the mixed-phase layer-by-layer because our synchrotron needs
approximately 2 s to change energy (layer) and the starting phase would differ
layer-by-layer, which would case a more blurred dose distribution three dimensionally.
Further experimental study is needed extend our present results to the more realistic
case with volumetric and inhomogeneous structures more realistically representing
patient anatomy.
The experiments undergone in this study focused on the interplay effect based
on a single layer in water equivalent homogeneous material. The main drawbacks in
this study are first of all that it did not account for the dose contribution from other
layers or other beam energies and might represent a worse case of the interplay effect
than a study with a volume target. Secondly this study did not account for the interplay
effect in the beam depth direction because the density of the moving object was
homogeneous. In a more heterogeneous case, for example in lung cancer, the water
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equivalent path length to each planned spot position drastically varies due to
inhomogeneous object motion, for which many spots pass through or cannot stop at the
original planned spot position in beam depth as well as lateral beam position
uncertainty. This also causes dose inhomogeneity in the depth direction and occurs
spot-by-spot in spot beam delivery to moving inhomogeneous object.
Ideally in order to understand the interplay effect it might be possible to carry
out the experiment undergone in this study using a human phantom. However, it might
be very hard to analyze the dose distribution and how each cold and hot spot arise
because so many spot beams with different energies coming from different positions
are mixed and this is very confusing. As the scan pattern is more complicated for such
a clinical case, it would be much more difficult to interpret the interplay effect. Thus,
initial study of the interplay effect should be performed with a very simple scanning
pattern and a 2D dose distribution on a single scan layer such as done in this study.
Therefore, the experimental results obtained in this study provided very important
information for basic comprehension of the interplay effect. This study could next be
extended to volume scanning beam delivery to homogeneous and simple
inhomogeneous objects composed of a few materials.
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6.5 Conclusions
The impact of the motion on 2D dose distributions for a single energy layer was
investigated by experiment. In the presence of motion, the delivered dose distribution
was typically distorted and non-uniform. These dose inhomogeneities are related to not
only the scan pattern but also the motion pattern e.g. motion amplitude and cycle.
However, if the motion amplitude was less than 5 mm, there was less dosimetric
impact (<2~5 % difference in homogeneity) regardless of motion cycle, number of
paintings, and the beam starting phase conditions. However, if the motion was larger
than 10 mm, these scan and motion conditions considerably affect the dose
inhomogeneity. The worst cases were 17% and 7.2 % dose difference inhomogeneity
for 10 and 20 mm motion amplitudes compared to the dose distribution with no
motion. However, these dose inhomogeneities were improved up to 7.0% and 2.7% for
20 mm and 10 mm motion for each by repainting. These results serve as the basis for
further interplay effect studies such as volume scanning in an inhomogeneous object. It
might be also directly applicable for a clinical case with a target whose beam path is
composed of nearly water equivalent materials. Furthermore the results in this study
propose that the respiratory gating technique is needed for scanning beam delivery to a
moving target with motion amplitude > 10mm.
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Chapter 7. Specific aim 2: Beam scanning delivery Part II
Assess the accuracy of dose delivery in respiratory gated proton therapy in
scanning beam delivery: A verification experiment of respiratory gated spot
scanning beam delivery

7.1 Introduction
The interplay effect study discussed in the previous chapter showed that for scanning
beam delivery motion less than 5 mm can be ignored. However, when motion is 1 cm
or greater, the dosimetric impact due to motion causes a dose deterioration and the
dose homogeneity depends both on the number of paintings and the scan direction.
Employing a respiratory gating beam delivery technique for the case of the motion
larger than 1 cm in spot scanning mode may improve dose homogeneity and help to
mitigate the effects of motion.
The main concern about employing respiratory gating techniques into a
synchrotron based beam delivery system is first, if all spots cannot be delivered within
one respiration gate, there could be a lack of continuity of the relative spot and target
positions between the phase when the beam delivery has stopped in the previous gate
and the phase when the next beam delivery will start in the next breathing gate. This is
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in principal caused by a specific synchrotron issue in that a spill extracted from a
synchrotron is not always ready when the respiratory gating system becomes ready to
start beam delivery. In other words, the spill delivery can be initiated randomly within
the respiratory gate-on status. The interplay effect was the main concern in the
previous chapter, but in this chapter the interplay effect between respiration gates on
one layer scan is more important in synchrotron based respiratory gated spot scanning
beam delivery. The interplay effect may also affect the volumetric dose distribution
and even the 2D dose in the case that the multiple painting cannot be completed within
one respiration gate.
In this section, the purpose is to investigate the feasibility of respiratory gated
beam delivery for synchrotron based spot scanning by experiment. The experiment and
dosimetric comparison performed in previous chapter were repeated with respiratory
gating.
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7.2 Materials and Methods
The equipment, procedure and analysis performed for these measurements were the
same as in the previous chapter. For details of the measurements, one should refer to
the Materials and Methods in the chapter 6-2. Additional equipment newly used for
the respiratory gating experiment is explained below.

7.2.1 Respiratory gating system
The respiratory gating system was developed for this study. It is composed of a laser
displacement sensor (ZS-LDS2VT, Omron, Japan) and a control unit (figure 7-1a). The
laser sensor measures the distance from the sensor to the surface of an object. The
control unit is mainly composed of an AD converter and digital signal circuits for
generating a gate signal. It converts and transfers the signal from the laser sensor to a
laptop PC. In-house software displays the signal from the control unit in a frame ratio
of 100 ms (figure 7-1b). The gate-on threshold level can be variable, and under the
gate threshold level the software sends a gate signal to ZENKEI via the control unit.
The mechanical delay of the gate signal between the software and the control unit is
less than 10 ms (figure 7-1c).
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(a)

(b)

(c)

Figure 7- 1. System outline of the respiration gating unit and software.
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7.2.2 Setup for measurements with the respiratory gating unit
Under the same setup condition as in the previous chapter, the laser sensor was set near
the edge of the moving platform in the direction of platform motion (figure 7-2). Since
the moving phantom, 2D chamber array and the solid water phantom move together in
rigid motion, there is no difference where the laser sensor measures in the part of this
unit. When the platform moves, the sensor measures the distance from the sensor to a
certain point on the platform. This dynamically changing distance was measured as
platform motion and displayed on the software.
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Lasor

Figure 7- 2. Setup of the laser sensor in the measurement. The upper image is an
overview of the setup of the equipment. The lower image is the setup of the laser
displacement sensor, which measured the distance between the edge of the moving
platform (red spot seen on the image at the arrow) and the sensor.
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7.2.3 2D dose measurement
Information concerning the spot beam, conditions and procedure for the measurement
were same as in the previous chapter except for platform motion. The same
measurement was repeated with respiratory gating and it was compared with the results
without gating. This is summarized in table 7-1. Regarding the platform motion, the
same sinusoidal motion following the formula (formula 2-1 in the chapter 6) with n=4
was used and the cycle of the motion was also same and used, T= 3 s and 5 s; however,
the amplitude of the platform motion was fixed with 20 mm motion. In this situation,
the end-expiration phase corresponds to the platform position at y=+0, where the
center of the 2D chamber array detector was set at isocenter, and the end-inspiration
phase corresponds to y= -20mm, at the inferior position in the treatment couch
coordinate system explained in figure 7-3. Based on the 20 mm motion amplitude in
the SI direction, the respiratory gate level was set at 30% in the expiration phase
(figure 7-3). The platform motion under the 30% gate level, or the intra-fractional
motion under the gate level, was approximately 6 mm. The gate width for T=3 s and 5
s cycle of the sinusoidal motion was 1.1 s and 2.4 s for each. In principal, it is
impossible to complete one painting, including delivery of 169 spots, in T=3s motion.
On the other hand, it is probably possible to complete it in 5 s motion; however, this
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depends on when the beam delivery starts during the gate-on status. This is a
synchrotron specific problem with the respiration gating and depends on the
specification of synchrotron manufactured by each vendor.
This measurement focused on the dosimetric impact of such inter-play effect
within the 6 mm motion and interplay effect under the conditions listed in table 7-1.
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Figure 7- 3. Platform motion (sinusoidal motion) pattern and respiration gate
setting. The center of the 2D array ion chamber detector was set at the isocenter. Note
that the end-expiration position is set to y = 0, and the end-inspiration level at y = -2
cm.
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Beam information
Energy [MeV]
Measured Depth [mm]
Spot size [FWHM mm]
Spot Spacing [mm]
Spot delivery time
Scan field [cm2]
Number of spots
Time for single painting [s]

173.7 (200 mm in water)
195 in water (equivalent to ≈95%
dose)
19.6
8
4 ms delivery
3 ms to move to next spot position
10x10
13x13=169
1.18

Moving platform
Motion
Motion amplitude[mm]
Motion cycle[s]

sin4
20
3 and 5

Respiratory gate condition
Gate level
30%
Motion under the gate level[mm] 6
Gate duration time [s]
1.1 in T=3s motion
2.4 in T=5s motion
Measurement: Beam delivery
Number of paintings

1, 2 ,4 , 6 , 8 , 10 , 12

Scan direction

Orthogonal (to moving platform)
Parallel

Table 7- 1. Measurement conditions.
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7.2.4 Analysis
The 2D dose distribution with motion was normalized based on the absolute dose at the
center of the reference 2D dose. The relative 2D dose distributions obtained under each
condition were compared by means of the dose homogeneity ratio, Hn/Href, where H is
the dose homogeneity. This is the ratio of the dose homogeneity with gating (with
motion) to static (no motion) for each number of paintings (n). Details of dose
homogeneity were explained in the previous chapter. The dose homogeneity was
calculated inside of three types of regions of interest (ROI)s, including the 95%, 90%
and 50% isodose lines, ROI95, ROI90 and ROI50, which were based on the reference
dose distribution (static, no motion) for each beam delivery condition (number of
paintings, n, and parallel or orthogonal scan pattern ). Href was computed inside of each
ROI, and Hn for each beam delivery condition was also calculated inside of the same
geometric area of each ROI (figure 7-4).
The homogeneity ratio Hn/Href=1 means that there is principally no difference
in the dose homogeneity between the 2D dose distribution with gated (with motion)
and static (without motion) beam delivery, where the static dose distribution is the
reference. In other words, in this case there would be no dose deterioration caused by
motion.
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7.2.5 Starting phase
In the free breathing based interplay effect study, the beam delivery starting phase was
a very relevant factor influencing the dose distribution. With respect to the respiratory
gating mode, beam delivery ideally was controlled under a certain phase of object
motion. Based on the current situation for respiratory gating, unfortunately, it is
technically impossible to initiate beam delivery precisely even at the gate-on phase
(under the gate threshold level). Therefore different types of beam delivery were
attempted in this set of measurements: for one, beam delivery was initiated within the
first half of respiration gated-on status, and thus beam delivery started in <1/2 of the
gate-on duration. Another was beam delivery starting in the latter half of the gate-on
status. The measurement was repeated several times at different phases among these
early and late phases, and maximum and minimum homogeneity ratios were
interpreted in the Results section.

189

Figure 7- 4. Schematic overview of the homogeneity calculation on each ROI,
including ROI95, ROI90 and ROI50. Each ROI was made based on 95%, 90% and
50% isodose lines on the static (no motion) dose distribution (left), named the
reference dose distribution. The homogeneity, Href, of the reference dose distribution
was computed inside of these ROIs. These ROIs were superimposed on each gated 2D
dose distribution (with motion, right) and the homogeneity, Hn (n: number of
paintings) was then calculated.
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7.3 Results
7.3.1 2D dose measurement
7.3.1.1 Scan pattern parallel to the platform motion with respiratory gating
Figure 7-5a shows the 2D dose distributions measured with a parallel scan pattern in a
single painting (13 lines × 13 spots = 169 spots) with respect to a 3 s motion cycle and
the signal outputs recorded during beam delivery. Figure 7-5b shows the signal outputs
of object motion (laser sensor), gate-on trigger, synchrotron magnet excitation pattern
and spill, or spot delivery (RF-on for beam extraction). Based on the signal
information, the actual delivered spot positions were approximately re-assigned on the
map assuming a 2D array detector (figure 7-5c). The completion of 169-spot delivery
needed tow spills in this case. As shown in figure 7-5b, the object position (expressed
as the motion amplitude, cm) at the end of the first spill was quite different from the
object position at the beginning of the next spill. The first spot in the second spill
(figure 7-5c, red circle) was not delivered at the correct position that was supposed to
be next to the end of the last spot in the first spill (blue circle in figure 7-5c), there was
gap of approximately 6 mm between the spills. This caused a cold spot seen in the
middle of the field in figure 7-5a. During spot beam delivery in each spill, the object
motion influenced the dose distortion especially seen on the top and bottom peripheral
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regions. However, there was no continuity between these dose distortions between the
spills. This consequently generated the winding distortion shape in the top and bottom
penumbras. The dose distortion occurring in each spill was associated with the
intra-spill object motion, and the cold (or hot) spot and the discontinuities in the dose
distortion were associated inter-spill object position error. This effect was considerably
influenced by the number of paintings, and the dose distortion and cold (hot) spots
were barely visible with 4 times paintings. Figure 7-6 shows the impact of multiple
paintings on the distorted 2D doses.

7.3.1.2 Scan pattern orthogonal to the platform motion with respiratory gating
Figure 7-7 shows the 2D dose distributions measured with the orthogonal scan pattern
in single painting with respect to a 3 s motion cycle (figure 7-7a), the signal outputs
recorded during beam delivery (figure 7-7b) and the reassigned delivered spot position
(figure 7c). Contrary to the results for the parallel scan pattern, figure 7-7c showed that
not only the shift between scan lines caused by the motion but also the position of the
individual spots in the scan line was considerably influenced by the motion. The scan
line ran obliquely in the worst case of intra-spill object motion. In addition, the spot
position error due to inter-spill object motion uncertainty occurred between the end of
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the first spill and the beginning of the second spill. The unbalanced delivered spots
shown in the middle of the field (0<y <2 cm) seen in figure 7-7c reflected on the hot
and cold spots in figure 7-7a. The cold and hot spots caused by both intra- and
inter-spill object motion were more sensitive than the results for the parallel scan
pattern. Figure 7-8 shows the impact of the multiple times of painting (re-painting) on
the intra- and inter-spill motion effect. The dose distribution was not smeared as well
as with the parallel scan pattern, which is seen even in dose distributions for 8 times
paintings or more.
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Figure 7- 5. Result of single painting in the parallel scan direction and signal
outputs during beam delivery. (a) The measured 2D dose distribution in the case of a
3 s motion cycle. (b) The signal output of the moving platform (blue), respiratory gate
status (cm, orange), gate threshold (arbitrary units, light green), synchrotron magnet
excitation pattern (arbitrary units, dark green) and RF kicker for beam extraction:
indirectly expressing spill beam extraction (arbitrary units, pink). (c) Based on the
signal outputs, the actual delivered spot positions were reassigned on the map.
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T=3s

T=5s

Figure 7- 6. Dose distribution with the parallel scan pattern (x1~12 paintings)
with a 3 s motion and gating (upper) and a 5 s motion cycle (lower).
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Figure 7- 7. Result of single painting in the orthogonal scan direction and signal
outputs during beam delivery. (a) The measured 2D dose distribution in the case of
3s motion cycle. (b) The signal output of the displacement of the moving platform (cm,
blue), respiratory gate status (arbitrary units, orange), gate threshold (light green),
synchrotron magnet excitation pattern (arbitrary units, dark green) and RF kicker for
beam extraction: indirectly expressing spill beam extraction (arbitrary unit, in pink).
(c) Based on the signal outputs, the actual delivered spot positions were reassigned on
the map.
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Figure 7- 8. Dose distribution with the orthogonal scan pattern (x1~12 paintings)
with 3 s motion and gating (upper) and a 5 s motion cycle (lower).
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7.3.2 Analysis: Dose homogeneity
7.3.2.1 Parallel scan direction beam delivery with respiratory gating
The measured 2D dose distributions and the dosimetric impact of the number of
paintings for each motion cycle shown in figures 7-6 (a) and (b) were compared with
respect to the dose homogeneity ratio for each motion cycle in figures 7-9(a) and (b).
Since the reduction in the homogeneity ratio accounting for the starting phase effect
was below 1% for all results, only the worst results were plotted on each graph. Both
graphs show all the homogeneity ratios, Hn/Href : the dose homogeneity ratio of gated
motion to no motion, were above 0.98 for each isodose comparison regardless of the
number of paintings in the parallel scan pattern and both object motion cycles. The
homogeneity ratio for a single painting shown in figure 7-5 was worse for the 95%
(ROI95) and 90% (ROI90) isodose comparison than for the 50% (ROI50) isodose
comparison due to the appearance of cold spots and the distortion around the
penumbra. This should not imply that the dose homogeneity was improved, however.
In the 50% isodose area the homogeneity ratio was conversely increased by the high
dose distribution contributing the penumbra reason due to the distortion. Except for the
case of a single painting, there was a 2% difference in dose homogeneities between the
gated and static dose distributions for all isodose areas of both motion cycles
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(σ=0.15%). There was a dosimetric impact caused by the intra-spill object motion and
inter-spill object position uncertainty with respiratory gating; however it was less than
2% for more than two times paintings for the parallel scan pattern. It is noted again that
even for a single painting, the homogeneity ratio was above 0.98.

7.3.2.2 Orthogonal scan direction beam delivery with respiratory gating
Figure 7-10 showed the homogeneity ratio of the 2D dose distributions shown in figure
7-8. Since the results including the starting phase effect made some differences in the
same measurement conditions, the graphs of the homogeneity ratio for the motion
cycle of 3 s (upper) and 5 s (lower) showed the worst and best results plotted for each
number of paintings. As seen in figure 7-8, the hot and cold spot yield influenced the
dose homogeneity in the high dose areas. The worst homogeneity ratios for ROI95,
ROI90 and also ROI50 were below 0.95.
For the homogeneity ratio with a 3 s motion cycle and 2 times paintings,
ROI95 and ROI90 were still below 0.95 in the worst case. However this gradually
improved from four paintings and became above 0.96 and finally above 0.98 from 8
paintings. In addition, the starting phase effect was also minimized with a 1%
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difference between the best and worst results except for the result of ROI95 and 6
paintings.
For the homogeneity ratio with 5 s motion, the starting phase did not have as
much influence on the results of 3s after 2 paintings. The homogeneity ratio for all
cases was also above 0.96 and reached 0.98 for 6 paintings. There was a slight
difference in the dose homogeneity associated with the speed of the platform motion
for 1-4 paintings.
The impact of the starting phase still had an influence on the dose
homogeneity due to production of cold and hot spots. Over 6 times paintings, the
homogeneity ratio become above 0.98 and there were almost no differences in dose
distributions between motion for both 3 s and 5 s with gating and no motion. In
addition the impact of the starting phase effect could be ignored with re-painting. The
dosimetric impact caused by the intra-spill object motion and inter-spill object position
uncertainty with respiratory gating became minimized and maintained consistency for
more than 6 times paintings in the orthogonal scan pattern to the object motion.
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Figure 7- 9. Homogeneity ratio with the orthogonal scan pattern for 3s (upper)
and 5s (lower) motion cycle and its improvement by re-painting for each motion
pattern. Each plot of the homogeneity ratios of the 95%, 90% and 50% ROIs for each
number of paintings was slightly shifted to avoid overlap for each number of paintings.
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Figure 7- 10. Homogeneity ratio by orthogonal scan pattern for 3 s (upper) and 5
s (lower) motion cycles and its improvement by re-painting for each motion
pattern. The worst and best homogeneity ratios were plotted for each condition (two
plots for each condition). Each plot of the homogeneity ratios of the 95%, 90% and
50% ROIs for each number of paintings was slightly shifted to avoid overlap for each
number of paintings.
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7.4 Discussion
The experiments performed in this study examined the dosimetric impact caused by
use of respiratory gated spot beam delivery to the moving object. The concern in this
experiment was the dose deterioration and loss of homogeneity due to the intra-spill
object motion and inter-spill object position uncertainty caused by the respiratory
gating. The result represented showed that parallel scan pattern had less dosimetric
impact than the orthogonal scan pattern. This minimized the impact within less than
2% by two paintings even in the peripheral dose area. In the previous study, it was
demonstrated that the parallel scan pattern had more motion tolerance than the
orthogonal scan pattern in the dosimetric impact of the scanning beam delivery for free
breathing, no gating or continuous, motion. In the present study, the intra-spill object
motion and inter-spill object position uncertainty were also main concerns for the
dosimetric impact due to non-gated motion especially in synchrotron based scanning
beam delivery. However the spill length for non-gated scanning is approximately 5
second at maximum, during which the beams delivery is available, and it is more than
2~4 times longer than the duration time of the 30% duty cycle based the respiration
gate (1.1 s for 3s and 2.4 s for 5 s motion) at the PTC. The intra-spill position
uncertainty indeed occurs approximately once in every 4 times paintings at the same
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energy layer (no energy change) with the 13×13=169 spot delivery pattern used in this
experiment. Therefore the inter-spill position uncertainty might have greater impact on
the dose distributions with respiratory gated scanning because the number of spills is
ultimately increased by use of the respiratory gating.
The results of the dose distributions and the dose homogeneity ratio included
about 6 mm motion uncertainty during the gate-on phase. These were 0.98 in a single
paint and above 0.99 in more than 2 paintings with the parallel scanning pattern using
respiratory gating. While the homogeneity ratios with 5 mm non-gated, or free
breathing with the same parallel scan beam delivery condition performed in the chapter
6 was above 0.99 for all conditions, including the numbers paintings, any starting
phase and both 3 s and 5 s motion cycles. Except the single painting, the use of
respiratory gating with a certain motion amplitude within the gate-on phase in the
parallel scanning pattern to the moving object can offer as the accurate beam delivery
as the case of the same motion amplitude in free-breathing (without respiratory gating)
with less than a 30% duty cycle gate threshold.
Similarly, regarding the orthogonal scanning pattern, the dose homogeneity
ratio of the 95% and 90% isodose areas were above 0.98 for all measured conditions,
including single painting. However, there was a worst case result that the dose
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homogeneities of 50% isodose area with a 3 s motion cycle were ranging from 0.95 up
to 0.98 regardless of the number paintings. This was associated with the starting phase
effect. A similar issue occurred in the case of 5 s motion; however, there were two
values of 0.97 in homogeneity and the others were above 0.98. According to the result
for the same scan pattern with respiratory gating obtained in this study, the same or
better dose homogeneity, 0.98, was offered from 6 paintings for both 3 and 5 s motion,
and, in this case, the homogeneity of 50% isodose was better than the result of the free
breathing case. This indicated that the dose distribution of the penumbra area was
improved by respiratory gating.
The dosimetric impact with respiratory gating was investigated from the
viewpoint of the number of paintings, scan pattern and motion cycle. The difference in
the motion cycle, associated with the speed of the object motion against the scanning,
turned out to have no impact on the dose distributions in the parallel scan pattern.
Contrary to this, in the orthogonal scan pattern, the dose homogeneity for 3 s motion
was 2~3% worse than the 5 s case for 95, 90 and 50% isodose areas from 1 up to 4
paintings, which was more influenced by the starting phase. However, there was no
difference after 6 paintings.
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Bert et al (2009) reported the relationship between spot size and a gate width able to
preserve a 5% deviation on 1×1 mm2 and 2×2 mm2 scan grids. The authors found that
for a 18 mm FWHM spot size, up to approximately a 6 mm gate width can offer a dose
deviation within 5% on a 2×2mm2 scan grid. The experiments in the present study
produced both better and worse results than this value depending on the starting phase
for the case of a single painting with same scan direction pattern (orthogonal). Since
the scan grid size and object motion pattern were quite different, it is difficult to
analyze the difference in these results. This difference does suggest that tighter spot
spacing does not always guarantee mitigation of the interplay effect caused by motion.
In carbon scanning beam delivery with respiratory gating, Furukawa (2010 and 2007)
reported that the interplay effect of the carbon beam can be mitigated, with a spot size
of less than half that produced by the PTC, with at least 6 paintings employing the
phase control rescanning method, which utilizes a highly sophisticated synchrotron
operation and beam delivery system. On the other hand, the present study
demonstrated that a larger spot size can easily provide motion tolerant scanning beam
delivery regardless of the intra-spill motion and inter-spill position uncertainty
associated with synchrotron operation in respiratory gating. This is also achievable
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with a fewer number paintings as long as an appropriate scan direction is selected,
which leads to highly efficient scanning beam delivery with respiratory gating.

7.5 Conclusions
Respiratory gated spot scanning beam delivery with a synchrotron has been
experimentally investigated in this study. There were some concern about the interplay
effect associated specifically with synchrotron operation, inter-spill object position
uncertainty and intra-spill object motion. From the experimental results with a gate
level equivalent to a 30% duty cycle, which produces 6 mm motion within the gate, the
scan pattern parallel to the moving object can mitigate the interplay effect in
respiratory gated scanning beam delivery within a 2% difference compared with the
static (no motion) dose distribution regardless of motion cycle. Even in the worse case
of the orthogonal scan pattern, it is possible to reduce the dosimetric impact due to the
interplay effect to 4% by 4 times paintings regardless of the motion cycle or more than
2 % difference in dose homogeneity by more than 6 times paintings compared with the
no motion case.
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Chapter 8. Conclusions of the dissertation and Future work
8.1 Conclusions of the dissertation
Simulation and experimental studies undergone in this dissertation provide strong
supporting data for the hypotheses stated in chapter 1. In the chapter 3, figure 3-4
demonstrated that the variable flat top synchrotron operation pattern is the most
efficient synchrotron operation pattern suitable for respiratory gating. Figure 3-10
showed the degree to which the efficiency is decreased for some conditions in our
synchrotron based respiratory gated spot scanning beam delivery. These results
provide important information when one attempts to implement respiratory gating
beam delivery. These results are used to assess the efficiency of respiratory gated
proton dose delivery, which is stated in specific aim 1.
Chapter 5 provides an investigation of how respiratory gated beam delivery is
affected by residual motion in passively scattered mode. Figure 8-1 summarized the
average values from figure3-10 and figure 5-9. The supporting data was used to
analyze the precision in the beam delivery in passively scattered beam delivery mode
with respiratory gating for each synchrotron operation pattern, Tcyc. This is the result of
the passively scattered mode in specific aim 2. The overall results for passively
scattered mode, from the efficiency point of view, show that the variable Tcyc operation
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is much better than the any other Tcyc operation. In addition, the beam delivery is
precisely undergone at a certain phase of the residual motion during beam delivery.
The lower the gate threshold level is, the more precise and uniform the beam delivery
is offered in passively scattered beam delivery mode. However, in this case, the
efficiency of the beam delivery with respiratory gating is worse; in other words, the
beam delivery time takes longer than in the case of a higher gate threshold setting.
In scanning beam mode, figures 4-3 and 4-4 in the chapter 4 showed the
simulation results of the relationship between scanning target volume and beam
delivery time with respiratory gating. From this one can conclude that the number of
scan layers has a stronger relationship with the beam delivery time rather than the
target volume (cm3). The efficiency of the use of the proton beam, determined by
MU/min, scarcely changes with the scanning volume. It is understandable that, as
shown in figure 4-4, the higher the gate threshold level is, the higher the efficiency is.
On the other hand, the chapter 6 and 7 showed that if the motion is less than 5 mm, the
impact of the motion on the dose distribution is almost negligible, and even if the
motion is larger than 5 mm, the combination of respiratory gating with the gate
threshold level when the residual motion is less than 5 mm and the use of the scanning
direction parallel to the target motion can achieve respiratory motion tolerant scanning
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beam delivery. The beam delivery time with gating and the beam efficiency with the
appropriate gate threshold level can be easily estimated from the figures 3-3 and 4-4.
This is how one can easily determine the most efficient and accurate respiratory gated
scanning beam delivery. These results comprise the latter part of specific aim 2
regarding scanning beam delivery mode.

Thus this dissertation has validated the hypothesis “Optimization of synchrotron
operating parameters can lead to greater efficiency and accuracy of respiratory
gating for all modes of synchrotron based proton treatment delivery”. All the data
provided in this dissertation were useful when implementing respiratory gating beam
delivery for both passively scattered and scanning beam delivery mode.
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Figure 8- 1. Efficiency and precision of passively scatted respiratory gated proton
beam delivery for each Tcyc. The open circles and squares represent the result of the
ratio of the effective MU/min with gating to the effective MU/min without gating
(figure 3-9 in the chapter 3). The solid circles and squares represent the ratio of
effective duty cycle to nominal duty cycle (figure 5-8 in chapter 5).

211

8.2 Future work
This dissertation has evaluated the dosimetric impact of the motion on a single energy
layer with and without the respiratory gated scanning beam delivery, and it has been
measured for homogeneous and water equivalent objects only. The dosimetric impact
of scanning beams in the depth direction was not taken into account. Therefore the
same measurement needs to be extended into a volumetric dose distribution using a
spot position (or scan) pattern composed of different energy layers, for example, a
10x10x10cm3 volume dose distribution. This is a more realistic evaluation accounting
for scanning beam delivery to the moving target either with or without respiratory
gating.
In order to deepen the respiratory gated scanning study for clinical
implementation, as a first step, the same experiment needs to be performed for a very
simple inhomogeneous object, composed of two materials; for example, water
equivalent and air (lung) equivalent materials, with motion. From a certain beam’s
point of view, the water equivalent thickness dynamically varies in a moving
inhomogeneous object. This causes a dosimetric impact in both the lateral and depth
directions simultaneously, and it is anticipated that the dose homogeneity would be
worse than the results discussed in this dissertation. Such an experiment would be
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closer to the dosimetric impact occurring inside of a real patient’s body. As suggested
above, it is very important for respiratory gated scanning delivery to evaluate the
dosimetric impact in lung because lung may best benefit by using respiratory gated
scanning delivery. Since the initial validation is completed, the same study will be
extended into the gated beam scanning to a volume target and then the same
measurement could be performed with a more complex object, for example a lung
phantom with motion. These careful investigations need to be performed for the
clinical implementation of respiratory gated scanning delivery.
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